0001104659-20-093964.txt : 20200812 0001104659-20-093964.hdr.sgml : 20200812 20200812170052 ACCESSION NUMBER: 0001104659-20-093964 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 66 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200812 DATE AS OF CHANGE: 20200812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bionik Laboratories Corp. CENTRAL INDEX KEY: 0001508381 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 271340346 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-54717 FILM NUMBER: 201096079 BUSINESS ADDRESS: STREET 1: 483 BAY STREET STREET 2: N105 CITY: TORONTO STATE: A6 ZIP: M5G2C9 BUSINESS PHONE: 1.416.640.7887 MAIL ADDRESS: STREET 1: 483 BAY STREET STREET 2: N105 CITY: TORONTO STATE: A6 ZIP: M5G2C9 FORMER COMPANY: FORMER CONFORMED NAME: Drywave Technologies, Inc. DATE OF NAME CHANGE: 20130814 FORMER COMPANY: FORMER CONFORMED NAME: Strategic Dental Management Corp. DATE OF NAME CHANGE: 20101220 10-Q 1 tm2024627-1_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x	Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 for the Quarterly Period ended June 30, 2020

¨	Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 for the transition period

Commission File Number: 000-54717

Bionik Laboratories Corp.

(Exact name of registrant as specified in its charter)

Delaware	27-1340346
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

483 Bay Street N105, Toronto, Ontario Canada M5G 2C9

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (416) 640-7887 x 508

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of Exchange on which registered
N/A		N/A		N/A

Securities registered pursuant to Section 12(g) of the Act: Common Stock, $0.001 par value

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	x	Smaller reporting company	x
		Emerging Growth Company	¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No x

The number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date. As of August 12, 2020, 5,009,151 shares of common stock, par value $0.001 per share were outstanding.

BIONIK LABORATORIES CORP.

TABLE OF CONTENTS

PART I – FINANCIAL INFORMATION
Item 1. Interim Financial Statements
Condensed Consolidated Interim Balance Sheets as at June 30, 2020 (Unaudited) and March 31, 2020 (Audited)	3
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss (Unaudited) for the three month periods ended June 30, 2020 and 2019	4
Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity (Unaudited) for the three month periods ended June 30, 2020 and 2019	5
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) for the three month periods ended June 30, 2020 and 2019	6
Notes to Condensed Consolidated Interim Financial Statements (Unaudited)	7
Item 2. Management’s Discussion and Analysis of Financial Conditions and Results of Operations	16
Item 3. Quantitative and Qualitative Disclosures about Market Risk	24
Item 4. Controls and Procedures	24
PART II – OTHER INFORMATION	24
Item 1. Legal Proceedings	24
Item 1A. Risk Factors	24
Item 2. Unregistered Sales of Equity Securities ad Use of Proceeds	24
Item 3. Defaults Upon Senior Securities	24
Item 4. Mine Safety Disclosures	24
Item 5. Other Information	24
Item 6. Exhibits	25
SIGNATURES	26

Bionik Laboratories Corp.

Condensed Consolidated Interim Balance Sheets (unaudited)

(Amounts expressed in US Dollars)

	As at			As at
	June 30, 2020			March 31, 2020
	$			$
				(Audited)
Assets
Current
Cash and cash equivalents		2,403,037			2,269,747
Accounts receivable, net of allowance for doubtful accounts of $Nil (March 31, 2020 - $167,500)		975,272			846,964
Prepaid expenses and other receivables (Note 5)		1,723,353			1,632,555
Inventories (Note 6)		944,990			1,059,462
Due from related parties (Note 9(a))		18,657			17,840
Total Current Assets		6,065,309			5,826,568
Equipment (Note 7)		136,032			154,144
Technology and other assets (Note 4)		1,426,420			1,449,924
Goodwill		11,085,984			11,085,984
Total Assets		18,713,745			18,516,620

Liabilities and Shareholders' Equity
Current
Accounts Payable (Notes 9(b))		443,874			857,093
Accrued liabilities (Notes 8 and 9(b))		2,057,784			1,647,656
PPP Loan (Note 8 (c))		459,912			-
Convertible Loans (Note 8(a) (b))		3,452,680			2,078,833
Deferred revenue - Contract Liabilities		582,281			616,063
Total Current Liabilities		6,996,531			5,199,645
Shareholders' Equity
Preferred Stock, par value $0.001; Authorized 10,000,000 Special Voting Preferred Stock, par value $0.001; Authorized; Issued and outstanding - 1 (March 31, 2020 – 1)		-			-
Common Shares, par value $0.001; Authorized - 500,000,000; Issued and outstanding 5,009,151 and 117,683 Exchangeable Shares (March 31, 2020 5,009,151 and 117,683 Exchangeable Shares)		5,126			5,126
Additional paid in capital		85,050,885			84,643,570
Deficit		(73,380,946	)		(71,373,870	)
Accumulated other comprehensive income		42,149			42,149
Total Shareholders' Equity		11,717,214			13,316,975
Total Liabilities and Shareholders' Equity		18,713,745			18,516,620

Commitments and Contingencies (Note 13)

Subsequent Events (Note 14)

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

Bionik Laboratories Corp.

Condensed Consolidated Interim Statements of Operations and Comprehensive Loss

For the three month periods ended June 30, 2020 and 2019 (unaudited)

(Amounts expressed in U.S. Dollars)

	Three months ended			Three months ended
	June 30, 2020			June 30, 2019
	$			$
Sales		257,908			790,379
Cost of Sales		62,555			336,085
Gross Margin		195,353			454,294

Operating expenses
Sales and marketing		223,185			583,732
Research and development		353,263			816,523
General and administrative		1,128,510			841,693
Share-based compensation expense (Notes 11)		407,315			287,757
Amortization (Note 4)		23,504			69,314
Depreciation (Note 7)		18,112			23,970
Total operating expenses		2,153,889			2,622,989

Other (income) expenses
Other expense		74,975			14,296
Other income		(37,612	)		-
Foreign exchange		11,177			(62,347	)
Total other income (expenses)		48,540			(48,051	)
Net loss and comprehensive loss for the period		(2,007,076	)		(2,120,644	)

Loss per share - basic and diluted		(0.39	)		(0.55	)

Weighted average number of shares outstanding – basic and diluted		5,126,834			3,858,637

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

Bionik Laboratories Corp.

Condensed Consolidated Interim Statements of Changes in Shareholders' Equity

For the three month periods ended June 30, 2020 and June 30, 2019 (unaudited)

(Amounts expressed in U.S. Dollars)

	Special Voting				Common Shares				Additional Paid					Comprehensive
	Shares		Amount		Shares		Amount		in Capital		Deficit			Income		Total
			$				$		$		$			$		$
Balance, March 31, 2019		1		-		3,858,637		3,858		73,719,299		(46,357,373	)		42,149		27,407,933
Share compensation expense										287,757							287,757
Net loss for the period												(2,120,644	)				(2,120,644	)
Balance, June 30, 2019		1		-		3,838,637		3,858		74,007,056		(48,478,017	)		42,149		25,575,046
Share compensation expense										1,493,855							1,493,855
Conversion of Promissory Note						1,268,191		1,268		9,142,659							9,143,927
Net loss for the Year												(22,895,853	)				(22,895,853)
Adjustment due to 1:150 share adjustment consolidation round up						6
Balance March 31, 2020		1		-		5,126,834		5,126		84,643,570		(71,373,870	)		42,149		13,316,975
Share compensation expense										407,315							407,315
Net loss for the period												(2,007,076	)				(2,007,076	)
Balance June 30, 2020		1		-		5,126,834		5,126		85,050,885		(73,380,946	)		42,149		11,717,214

The Accompanying notes are an integral part of these condensed consolidated interim financial statements.

Condensed Consolidated Interim Statements of Cash Flows

For the three month periods ended June 30, 2020 and 2019 (unaudited)

(Amounts expressed in U.S. Dollars)

	Three months ended			Three months ended
	June 30, 2020 $			June 30, 2019 $
Operating activities
Net loss for the period		(2,007,076	)		(2,120,644	)
Adjustment for items not affecting cash
Depreciation		18,112			23,970
Amortization		23,504			69,314
Interest expense		74,975			13,283
Share based compensation expense		407,315			287,757
		(1,483,170	)		(1,726,320	)
Changes in non-cash working capital items
Accounts receivable		(128,308	)		496,181
Prepaid expenses and other receivables		(90,798	)		160,305
Due from related parties		(817	)		(483	)
Inventories		114,472			(176,376	)
Accounts payable		(413,219	)		(93,835	)
Accrued liabilities		406,425			(41,434	)
Deferred revenue		(33,782	)		58,016
Net cash (used in) operating activities		(1,629,197	)		(1,323,946	)
Investing activities
Acquisition of equipment		-			(42,802	)
Net cash (used in) investing activities		-			(42,802	)
Financing activities
Proceeds from convertible loans		1,302,575			950,000
Proceeds from PPP Loan		459,912			-
Proceeds from term loan		-			500,000
Net cash provided by financing activities		1,762,487			1,450,000
Net increase in cash and cash equivalents for the period		133,290			83,252
Cash and cash equivalents, beginning of the period		2,269,747			446,779
Cash and cash equivalents, end of the period		2,403,037			530,031

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

BIONIK LABORATORIES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the three month periods ended June 30, 2020 and 2019

(Amounts expressed in U.S. Dollars) (unaudited)

NATURE OF OPERATIONS AND GOING CONCERN

The Company and its Operations

Bionik Laboratories Corp. (the “Company” or “Bionik”) was incorporated on January 8, 2010 in the State of Colorado as Strategic Dental Management Corp. On July 16, 2013, the Company changed its name to Drywave Technologies Inc. (“Drywave”) and its state of incorporation from Colorado to Delaware. Effective February 13, 2015, the Company changed its name to Bionik Laboratories Corp. and reduced the authorized number of shares of common stock from 200,000,000 to 150,000,000. Concurrently, the Company implemented a 1-for-0.831105 reverse stock split of the common stock, which had previously been approved on September 24, 2014. On October 29, 2018, the Company implemented at 1 for 150 reverse stock-split of the common and exchangeable shares.

On February 26, 2015, the Company entered into a Share Exchange Agreement and related transactions whereby it acquired Bionik Laboratories Inc., a Canadian Corporation (“Bionik Canada”) and Bionik Canada issued 333,334 Exchangeable Shares, representing a 3.14 exchange ratio, for 100% of the then outstanding common shares of Bionik Canada (the “Merger”). The Exchangeable Shares are exchangeable at the option of the holder, each into one share of the common stock of the Company. In addition, the Company issued one Special Preferred Voting Share (the “Special Preferred Share”) (Note 10).

On April 21, 2016, the Company acquired all of the outstanding shares and, accordingly, all assets and liabilities of Interactive Motion Technologies, Inc. (IMT), a Boston, Massachusetts-based global pioneer and leader in providing effective robotic products for neurorehabilitation, pursuant to an Agreement and Plan of Merger (the “Merger Agreement”) dated March 1, 2016, with IMT, Hermano Igo Krebs, and Bionik Mergerco Inc., a Massachusetts corporation and the Company’s wholly owned subsidiary (Bionik Mergerco). The merger agreement provided for the merger of Bionik Mergerco with and into IMT, with IMT surviving the merger as the Company’s wholly owned subsidiary. In return for acquiring IMT, IMT shareholders received an aggregate of 157,667 shares of the Company’s common stock (Note 4).

On November 6, 2017, the Company approved an increase in its authorized shares of common stock to 250,000,000 from 150,000,000, and on June 12, 2018, the Company approved an increase in its authorized shares of common stock to 500,000,000 from 250,000,000.

References to the Company refer to the Company and its wholly owned subsidiaries, Bionik Inc., Bionik Acquisition Inc. and Bionik Canada.

The Company is a global pioneering robotics company focused on providing rehabilitation solutions to individuals with neurological disorders, specializing in designing, developing and commercializing cost-effective physical rehabilitation technologies, prosthetics, and assisted robotic products. The Company strives to innovate and build devices that can rehabilitate and improve an individual’s health, comfort, accessibility and quality of life through the use of advanced algorithms and sensing technologies that anticipate a user’s every move.

These unaudited condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), which contemplates continuation of the Company as a going concern, which assumes the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.

The Company’s principal offices are located at 483 Bay Street, N105, Toronto, Ontario, Canada M5G 2C9 and its U.S. address is 80 Coolidge Hill Road, Watertown, MA 02472.

Going Concern

As at June 30, 2020, the Company had a working capital deficit of $931,222 (March 31, 2020 - working capital of $626,923) and an accumulated deficit of $73,380,946 (March 31, 2020 - $71,373,870) and the Company incurred a net loss and comprehensive loss of $(2,007,076) for the three month period ended June 30, 2020 (June 30, 2019 - $(2,120,644).

There is no certainty that the Company will be successful in generating sufficient cash flow from operations or achieving and maintaining profitable operations in the future to enable it to meet its obligations as they come due and consequently continue as a going concern.

BIONIK LABORATORIES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the three month periods ended June 30, 2020 and 2019

(Amounts expressed in U.S. Dollars) (unaudited)

NATURE OF OPERATIONS AND GOING CONCERN – Continued

The Company will require additional financing to fund its operations and it is currently working on securing this funding through corporate collaborations, public or private equity offerings or debt financings. Sales of additional equity securities by the Company would result in the dilution of the interests of existing stockholders. There can be no assurance that financing will be available when required. In the event that the necessary additional financing is not obtained, the Company would reduce its discretionary overhead costs substantially or otherwise curtail operations. The Company expects to raise additional funds to meet the Company’s anticipated cash requirements for the next 12 months; however, these conditions raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments to reflect the possible future effects on recoverability and reclassification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.

All adjustments, consisting only of normal recurring items, considered necessary for fair presentation have been included in these consolidated financial statements.

BASIS OF PRESENTATION

During the 2019 fiscal year, holders of the common stock and exchangeable shares of the Company approved, through a majority shareholder vote, an amendment to the Company’s Amended and Restated Certificate of Incorporation authorizing the Board of Directors to effect a reverse stock split of Bionik’s common stock and exchangeable shares at a ratio up to one-to-one hundred and fifty.

The preparation of these consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ materially from those estimates. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of June 30, 2020 and through the date of this report filing.

SIGNIFICANT ACCOUNTING POLICIES

Unaudited Condensed Consolidated Interim Financial Statements

These unaudited condensed consolidated interim financial statements have been prepared on the same basis as the annual audited financial statements of the Company and should be read in conjunction with those annual audited financial statements filed on Form 10-K for the year ended March 31, 2020. The interim disclosures generally do not repeat those in the annual statements. In the opinion of management, these unaudited condensed consolidated interim financial statements reflect all adjustments necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods shown. The results of operations for such periods are not necessarily indicative of the results expected for a full year or for any future period.

The changes in accounting policies in the Company’s unaudited condensed consolidated interim financial statements from the March 31, 2020 audited financial statements are described below.

BIONIK LABORATORIES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the three month periods ended June 30, 2020 and 2019

(Amounts expressed in U.S. Dollars) (unaudited)

SIGNIFICANT ACCOUNTING POLICIES - Continued

Newly Adopted and Recently Issued Accounting Pronouncements

Newly Adopted

In January 2017, the FASB issued ASU 2017-01, “Business Combinations: Clarifying the definition of a Business” which amends the current definition of a business. Under ASU 2017-01, to be considered a business, an acquisition would have to include an input and a substantive process that together significantly contributes to the ability to create outputs. ASU 2017-01 further states that when substantially all of the fair value of gross assets acquired is concentrated in a single asset (or a group of similar assets), the assets acquired would not represent a business. The new guidance also narrows the definition of the term “outputs” to be consistent with how it is described in Topic 606, Revenue from Contracts with Customers. The changes to the definition of a business will likely result in more acquisitions being accounted for as asset acquisitions. ASU 2017-01 is effective for acquisitions commencing on or after December 31, 2019, with early adoption permitted. Adoption of this guidance will be applied prospectively on or after the effective date and the Company does not expect this policy will have a material effect on the consolidated balance sheet or consolidated statement of cash flows.

BIONIK LABORATORIES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the three month periods ended June 30, 2020 and 2019

(Amounts expressed in U.S. Dollars) (unaudited)

SIGNIFICANT ACCOUNTING POLICIES - Continued

In January 2017, the FASB issued ASU 2017-04, “Intangibles – Goodwill and Other” ASU 2017-04 simplifies the accounting for goodwill impairment by eliminating Step 2 of the current goodwill impairment test, which required a hypothetical purchase price allocation.

Goodwill impairment will now be the amount by which the reporting unit’s carrying value exceeds its fair value, limited to the carrying value of the goodwill. ASU 2017-04 is effective for financial statements issued for fiscal years, and interim periods beginning after December 15, 2019. The Company has adopted ASU 2017-04 and it did not have a material effect on the consolidated balance sheet and consolidated statement of operations.

In June 2016, the FASB issued ASU 2016-13 Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments, which introduces an expected credit loss methodology for the impairment of financial assets measured at amortized cost basis. The methodology replaces the probable, incurred loss model for those assets. The update if effective for fiscal years beginning after December 15, 2019. The Company has adopted ASU 2016-13 and it did not have a material effect on the consolidated balance sheet and consolidated statement of operations.

Recently issued

Accounting Standards Update 2020-06—Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity: simplifies accounting for convertible instruments by removing major separation models required under current Generally Accepted Accounting Principles (GAAP). Consequently, more convertible debt instruments will be reported as a single liability instrument and more convertible preferred stock as a single equity instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU also simplifies the diluted earnings per share (EPS) calculation in certain areas. The amendments in this Update are effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is assessing the impact that the adoption of ASU 2020-06 will have on the consolidated balance sheet and consolidated statement of operations.

Canada Emergency Wage Subsidy (CEWS)

CEWS is recognized as other income in the consolidated statement of operations in the period in which the Company recognizes expenses for which CEWS is intended to compensate.

Warranty Reserve and Deferred Warranty Revenue

The Company provides a one-year warranty as part of its normal sales offering. When products are sold, the Company provides warranty reserves, which, based on the historical experience of the Company are sufficient to cover warranty claims. Accrued warranty reserves are included in accrued liabilities on the condensed consolidated interim balance sheets and amounted to $81,225 at June 30, 2020 (March 31, 2020 - $162,449). The Company also sells extended warranties for additional periods beyond the standard warranty. Extended warranty revenue is deferred and recognized as revenue over the extended warranty period. The Company recognized $Nil of expenses related to warranty expenses. Additionally, the Company reversed $81,224 of its warranty provision due to low warranty claims and recorded this expense and reversal in cost of goods sold for the three-month period ended June 30, 2020 (June 30, 2019 - $26,911).

TECHNOLOGY AND OTHER ASSETS

The schedule below reflects the intangible assets acquired in the IMT acquisition and the assets amortization period and expense for the three months ended June 30, 2020, and the year ended March 31, 2020:

	Amortization						Expenses		Value at		Expenses		Value at
	period		Value				March 31,		March 31,		June 30,		June 30,
	(years)		acquired		Impairment		2020		2020		2020		2020
Intangible assets acquired			$		$		$		$		$		$
Patents and exclusive License Agreement		9.74		1,306,031		307,388		134,090		469,962		20,277		449,685
Trademark		Indefinite		2,505,907		1,605,907		-		900,000		-		900,000
Customer relationships		10		1,431,680		787,245		143,168		79,962		3,227		76,735
Non compete agreement		2		61,366		-		-		-		-		-
Assembled workforce		1		275,720		-		-		-		-		-
				5,580,704		2,700,540		277,258		1,449,924		23,504		1,426,420

The cumulative amortization for the technology and other assets was $1,453,744 at June 30, 2020 (March 31, 2020- $1,430,240).

PREPAID EXPENSES AND OTHER RECEIVABLES

	June 30, 2020		March 31 2020
	$		$
Prepaid expenses and other receivables		34,272		78,816
Prepaid inventory		1,499,042		1,450,024
Prepaid insurance		176,928		57,226
Sales taxes receivable (i)		13,111		46,489
		1,723,353		1,632,555

Sales tax receivable represents net harmonized sales taxes (HST) input tax credits receivable from the Government of Canada.

BIONIK LABORATORIES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the three month periods ended June 30, 2020 and 2019

(Amounts expressed in U.S. Dollars) (unaudited)

INVENTORIES

June 30,

2020

March 31

2020

Finished Goods

944,990

1,059,462

During the three-month period ended June 30, 2020, the Company expensed $143,810 in inventory as cost of goods sold (June 30, 2019 - $299,795) offset by a warranty adjustment of $81,224. The Company no longer maintains a raw materials inventory as it has outsourced its manufacturing to a third party.

EQUIPMENT

Equipment consisted of the following as at June 30, 2020 and March 31, 2020:

	June 30, 2020						March 31, 2020
	Cost		Accumulated Depreciation		Net		Cost		Accumulated Depreciation		Net
	$		$		$		$		$		$
Computers and electronics		303,337		269,174		34,163		303,337		264,520		38,817
Furniture and fixtures		36,795		31,240		5,555		36,795		30,953		5,842
Demonstration equipment		135,543		49,395		86,148		135,543		37,662		97,881
Manufacturing equipment		88,742		86,789		1,953		88,742		86,688		2,054
Tools and parts		11,422		7,813		3,609		11,422		7,627		3,795
Assets under capital lease		23,019		18,415		4,604		23,019		17,264		5,755
		598,858		462,826		136,032		598,858		444,714		154,144

Equipment is recorded at cost less accumulated depreciation. Depreciation expense during the three-month period ended June 30, 2020 was $18,112 (June 30, 2019 - $23,970).

NOTES PAYABLE

(a)

Convertible Loans Payable

During the quarter ended June 30, 2020, the Company received $1,302,575, in addition to $70,000 previously loaned to the Company, pursuant to a $3,000,000 (later increased to $7,000,000) convertible note offering. The convertible notes bear interest at a fixed rate at 1% per month. The convertible loans will be convertible into equity of the Company upon the following events on the following terms:

(i)

On the Maturity Date, the outstanding principal and accrued and unpaid interest under the convertible note will be converted into shares of common stock at a conversion price of $8.55 per shares in the event of an investment on or prior to December 31, 2019, and $9.50 per share in the event of an investment after December 31, 2019 (the “Conversion Price”).

(ii)

Upon a change of control transaction prior to the Maturity Date, the outstanding principal and accrued and unpaid interest under the convertible notes would, at the election of the holders of a majority of the outstanding principal of the loans under the offering, be either (i) payable upon demand as of the closing of such change of control transaction or (ii) convertible into shares of the Company’s common stock immediately prior to such change of control transaction at a price per share equal to the lesser of (x) the Conversion Price or (y) the per share consideration to be received by the holders of the common stock in such change of control transaction.

In the event the Company raises capital through the sale of Common Stock for cash during the period ending on the three year anniversary of the issuance date of the convertible notes, and the price per share thereof (the “Offering Price”) minus 20% is less than the original Conversion Price, then in such event the Company shall issue to all convertible loan holder at, at no further cost, additional shares of common stock equal to the number of conversion shares the holders would have received upon conversion if the Conversion Price equaled to a 20% discount to the Offering Price, less the number of shares of conversion shares actually issued on or as of the Maturity Date. Since the Company has early adopted ASU 2017-11, the anti-dilution protection clause does not contribute to the conversion feature to be a derivative liability.

The interest accrued on these convertible loans for the period ended June 30, 2020 was $15,588 (March 31, 2020- $4,317).

BIONIK LABORATORIES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the three month periods ended June 30, 2020 and 2019

(Amounts expressed in U.S. Dollars) (unaudited)

NOTES PAYABLE – Continued

(b)

Short term loan

On March 23, 2020, the Company received a $2,000,000 loan from an existing shareholder. The promissory note bears interest at a fixed rate of 1% per month and has a maturity date of the earlier of (i) March 31, 2022 and (ii) the date of receipt of a minimum of US$5,000,000 from a “Subsequent Financing.” The accrued interest shall be payable one-half at the maturity date, and one-half on a quarterly basis as follows: (a) the quarterly interest payments shall be payable in cash commencing on the six month anniversary of the issue date (or the nine month anniversary of the issue date if as of such six month anniversary the World Health Organization (or a corresponding government or government agency) still categorizes or deems COVID-19 or the novel corona virus as a pandemic or outbreak) (the “First Interest Payment Date”), with the quarterly payments accruing for the first (or first two, as the case may be) interest payment dates nevertheless being payable, without further interest thereon, pro rata from the First Interest Payment Date through the maturity date. The loan is repayable or convertible to common shares at the loan holder’s option. Interest accrued on this loan at June 30, 2020 is $64,516 (March 31, 2020 – $4,516).

(c)

PPP Loan

On May 1, 2020, the Company signed a Promissory Note for $459,912 pursuant to the federal Paycheck Protection Program under the Coronavirus Aid, Relief and Economic Security Act, which is administered by the U.S. Small Business Administration. The loan is unsecured, bears interest of 1% per annum and a deferment period of 6 months. The loan is to be used primarily for payroll related costs, lease, and utility payments. The Company intends to apply for forgiveness for all or a portion of the loans in accordance with applicable law. If the loan is not forgiven, the Company will be obligated to repay the loan during the period of 2 years.

RELATED PARTY TRANSACTIONS AND BALANCES

(a)

Due from related parties

At June 30, 2020 there was an outstanding loan to the Chief Technology Officer (“CTO”) of the Company of $18,657 (March 31, 2020 - $17,840). The loan has an Interest rate of 2% based on the Canada Revenue Agency’s prescribed rate for such advances and is denominated in Canadian dollars. During the period ended June 30, 2020, the Company accrued interest receivable in the amount of $90 (March 31, 2020 – $472); the remaining fluctuation in the balance from the prior year is due to changes in foreign exchange.

(b)

Accounts payable and accrued liabilities

As at June 30, 2020, $193,285 (March 31, 2020 - $30,866) was owing to the CEO of the Company; $57,246 (March 31, 2020 – $9,464) was owing to the Chief Technology Officer; $70,963 (March 31, 2020 - $1,827) was owing to the Chief Financial Officer (“CFO”), $32,472 (March 31, 2020 - $Nil) was owing to the Chief Commercial Officer (“CCO”), all related to bonuses and business expenses.

10.

SHARE CAPITAL

	June 30, 2020				March 31, 2020
	Number of shares		$		Number of shares			$
Exchangeable Shares
Balance beginning of period		117,683		118		196,799			197
Converted into common shares (a)		-		-		(79,116	)		(79	)
Balance at end of period		117,683		118		117,683			118
Common Shares
Balance at beginning of the period		5,009,151		5,008		3,661,838			3,661
Shares issued to exchangeable shareholders (a)		-		-		79,116			79
Shares issued on conversion of loans		-		-		1,268,191			1,268
Share consolidation rounding adjustment		-		-		6			-
Balance at end of the period		5,009,151		5,008		5,009,151			5,008
TOTAL SHARES		5,126,834		5,126		5,126,834			5,126

(a)

During the quarter ended June 30, 2020, Nil exchangeable shares were exchanged for common shares on a 1 for 1 basis in accordance with their terms (March 31, 2020 – 79,116 shares).

BIONIK LABORATORIES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the three month periods ended June 30, 2020 and 2019

(Amounts expressed in U.S. Dollars) (unaudited)

10.

SHARE CAPITAL – Continued

Special Voting Preferred Share

In connection with the Merger (Note 1), on February 26, 2015, the Company entered into a voting and exchange trust agreement (the “Trust Agreement”). Pursuant to the Trust Agreement, the Company issued one Special Voting Preferred Share to the Trustee, and the parties created a trust for the Trustee to hold the Special Voting Preferred Share for the benefit of the holders of the Exchangeable Shares (the “Beneficiaries”). Pursuant to the Trust Agreement, the Beneficiaries will have voting rights in the Company equivalent to what they would have had, had they received shares of common stock in the same amount as the Exchangeable Shares held by the Beneficiaries. In connection with the Merger and the Trust Agreement, effective February 20, 2015, the Company filed a certificate of designation of the Special Voting Preferred Share (the “Special Voting Certificate of Designation”) with the Delaware Secretary of State. Pursuant to the Special Voting Certificate of Designation, one share of the Company’s blank check preferred stock was designated as Special Voting Preferred Share. The Special Voting Preferred Share entitles the Trustee to exercise the number of votes equal to the number of Exchangeable Shares outstanding on a one-for-one basis during the term of the Trust Agreement. The Special Voting Preferred Share is not entitled to receive any dividends or to receive any assets of the Company upon liquidation and is not convertible into shares of common stock of the Company. The voting rights of the Special Voting Preferred Share will terminate pursuant to and in accordance with the Trust Agreement and the Special Voting Preferred Share will be automatically cancelled.

11.

STOCK OPTIONS

The purpose of the Company’s equity incentive plan, is to attract, retain and motivate persons of training, experience and leadership to the Company, including their directors, officers and employees, and to advance the interests of the Company by providing such persons with the opportunity, through share options, to acquire an increased proprietary interest in the Company.

On September 1, 2017, the Company granted 81,436 options at $24.15 per share equally to an executive officer and a consultant, who is now the Chairman of the Company. 27,148 options have vested and 50% of the remaining options vest on performance being met and 50% vest annually over 5 years for the CEO, for our Chairman the options vest over 5 years. The grant date fair value was $1,832,304 and $57,259 is the current expense for the quarter ended June 30, 2020 (June 30, 2019 - $57,259).

On January 24, 2018, the Company granted 24,267 options at $23.25 per share to employees that vest equally on January 24, 2019, 2020 and 2021. 7,334 options were cancelled for the year ended March 31, 2019 and 266 for the three-month period ended June 30, 2020. The grant fair value was $491,036 and $28,554 is the current stock compensation expense for the quarter ended June 30, 2020 (June 30, 2019 - $28,554).

On May 31, 2019 169,882 options were issued to employees and directors of the Company with an exercise price of $3.16 per share that vest over 1 year and 6 months, of which one-third immediately vest and one-third vest over each of the next two 6-month periods. The options expire in 7 years. The options were valued using the Black Scholes model and the following inputs were used: expected life of 7 years, expected volatility of 114% and a risk-free rate of 1.59%. The grant fair value was $453,585 and $50,755 of stock compensation was recognized for the quarter ended June 30, 2020.

On July 26, 2019, 484,612 options were granted to employees and consultants at an exercise price of $3.595. The options were using the Black Scholes model and the following inputs were used: expected life of 7 years, expected volatility of 114% and a risk-free rate of 1.59%. The grant fair value was $1,525,525. 11,461 options were cancelled for the year ended March 31, 2020 and 1,286 were canceled and stock compensation of $269,579 was recognized in the quarter ended June 30, 2020.

On September 3, 2019, 5,000 options were granted to an employee at an exercise price of $3.20 which will vest over three years starting September 3, 2020. The options were valued using the Black Scholes model and the following inputs were used: expected life of 7 years, expected volatility of 114% and a risk-free rate of 1.59%. The grant fair value was $14,010 and $1,168 of stock compensation expense was recognized in the quarter ended June 30, 2020.

During the quarter ended June 30, 2020, the Company recorded $407,315 in share-based compensation related to the vesting of stock options (June 30, 2019 - $287,757).

BIONIK LABORATORIES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the three month periods ended June 30, 2020 and 2019

(Amounts expressed in U.S. Dollars) (unaudited)

11.

STOCK OPTIONS – Continued

The following is a summary of stock options outstanding and exercisable as of June 30, 2020:

Exercise Price ($)	Number of Options		Expiry Date	Exercisable Options
34.500		630	20-Jun-21		630
34.500		13,212	01-Jul-21		13,212
34.500		944	17-Feb-22		944
183.000		2,667	24-Nov-22		2,667
150.000		11,400	14-Dec-22		11,400
142.500		359	28-Mar-23		359
157.500		1,387	28-Mar-23		1,387
105.000		2,667	06-Feb-24		2,667
102.000		1,667	13-Feb-24		1,667
142.500		106	03-Mar-24		106
157.500		408	03-Mar-24		408
142.500		43	14-Mar-24		43
157.500		164	14-Mar-24		164
142.500		327	30-Sep-24		327
157.500		1,264	30-Sep-24		1,264
24.150		81,436	01-Sep-27		40,722
23.250		13,064	24-Jan-25		9,132
9.735		40,000	19-Apr-28		40,000
3.16		168,283	31-May-26		168,283
3.595		473,151	26-July-26		56,417
3.20		5,000	03-Sep-26		-
		818,179			351,798

The weighted-average remaining contractual term of the outstanding options is 6.02 years (March 31, 2020 – 6.28 years) and for the options that are exercisable the weighted average is 5.84 years (March 31, 2020 – 6.12 years).

12.

WARRANTS

The following is a continuity schedule of the Company’s common share purchase warrants:

	Number of			Weighted Average Exercise Price
	Warrants			($)
Outstanding and exercisable, March 31, 2019		288,517			40.27
Expired		(163,483	)		(38.91	)
Outstanding and exercisable, March 31, 2020		125,034			20.07
Expired		(2,667	)		(37.50	)
Outstanding and exercisable June 30, 2020		122,367			19.69

During the quarter ended June 30, 2020, 2,667 warrants expired in accordance with their terms.

BIONIK LABORATORIES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the three month periods ended June 30, 2020 and 2019

(Amounts expressed in U.S. Dollars) (unaudited)

12.

WARRANTS – Continued

Common share purchase warrants

The following is a summary of common share purchase warrants outstanding as of June 30, 2020.

Exercise Price ($)	Number of Warrants		Expiry Date
90.00		15,658		March 31, 2023
9.375		64,025		August 14, 2022
9.375		42,684		March 31, 2022
		122,367

The weighted-average remaining contractual term of the outstanding warrants was 2.07.

13.

COMMITMENTS AND CONTINGENCIES

Contingencies

From time to time, the Company may be involved in a variety of claims, suits, investigations and proceedings arising in the ordinary course of our business, collections claims, breach of contract claims, labor and employment claims, tax and other matters. Although claims, suits, investigations and proceedings are inherently uncertain and their results cannot be predicted with certainty, the Company believes that the resolution of current pending matters will not have a material adverse effect on its business, financial position, results of operations or cash flow. Regardless of the outcome, litigation can have an adverse impact on the Company because of legal costs, diversion of management resources and other factors.

Commitments

(a)

On February 25, 2015, 1,753 common shares were issued to two former lenders connected with a $241,185 loan received and repaid during fiscal 2013. The common shares were valued at $210,323 based on the value of the concurrent private placement and recorded in stock-based compensation on the consolidated statement of operations and comprehensive loss. As part of the consideration for the initial loan, the Company’s then-CTO and COO had transferred 2,098 common shares to the lenders. For contributing the common shares to the lenders, the Company intends to reimburse the former CTO and COO 2,134 common shares. As at June 30, 2020 these shares have not yet been issued.

(b)

On May 17, 2017, the Company entered into a Co-operative Joint Venture Contract (the “JV Contract”) with Ginger Capital Investment Holding, Ltd. (the “JV Partner”) to form China Bionik Medical Rehabilitation Technology Ltd. (“China JV”), pursuant to which, among other things, the Company was to have a 25% interest and the JV Partner a 75% interest. The Company applied the equity method of accounting to the joint venture.

The Company gave notice on May 18, 2020 to the JV Partner of the termination of the China JV as well as terminating the Licensing and Distribution agreements with the China JV. As a result of the termination of the China JV and related commercial agreements, the Company has been communicating with its counterparts regarding such termination.

(c)

In connection with the acquisition of IMT, the Company acquired a license agreement dated June 8, 2009, with a former director as a co- licenser, pursuant to which the Company pays the director and the co-licenser an aggregate royalty of 1% of sales based on patent #8,613,691. No sales have been made, as the technology under this patent has not been commercialized.

14.

SUBSEQUENT EVENTS

(a)

Subsequent to June 30, 2020, the Company received an additional $200,000 from lenders under the terms of the convertible loans described in Note 8 (a).

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

This Quarterly Report on Form 10-Q contains statements reflecting assumptions, expectations, projections, intentions, or beliefs about future events that are intended as “forward-looking statements”. All statements included or incorporated by reference in this Quarterly Report on Form 10-Q, other than statements of historical fact, that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward- looking statements. These statements appear in several places, including, but not limited to in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These statements represent our reasonable judgment of the future based on various factors and using numerous assumptions and are subject to known and unknown risks, uncertainties and other factors that could cause our actual results and financial position to differ materially from those contemplated by the statements. You can identify these statements by the fact that they do not relate strictly to historical or current facts, and use words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “may,” “will”, “should,” “plan,” “project” and other words of similar meaning. In particular, these include, but are not limited to, statements relating to the following:

·	projected operating or financial results, including anticipated cash flows used in operations.

·	expectations regarding capital expenditures; and

·	our beliefs and assumptions relating to our liquidity position, including our ability to obtain additional financing.

Any or all of our forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks, uncertainties and other factors including, among others:

·	the loss of key management personnel on whom we depend.

·	our ability to operate our business efficiently, manage capital expenditures and costs (including general and administrative expenses) and obtain financing when required; and

·	our expectations with respect to our acquisition activity.

In addition, there may be other factors that could cause our actual results to be materially different from the results referenced in the forward-looking statements, some of which are included in this Quarterly Report on Form 10-Q, including in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Many of these factors will be important in determining our actual future results. Consequently, no forward-looking statement can be guaranteed. Our actual future results may vary materially from those expressed or implied in any forward-looking statements. All forward- looking statements contained in this Quarterly Report on Form 10-Q are qualified in their entirety by this cautionary statement. Forward-looking statements speak only as of the date they are made, and we disclaim any obligation to update any forward-looking statements to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q, except as otherwise required by applicable law.

This discussion and analysis should be read in conjunction with the accompanying condensed consolidated interim financial statements and related notes, and the Company’s Annual Report on Form 10-K for the year ended March 31, 2020 as filed with the Securities and Exchange Commission.

The discussion and analysis of the financial condition and results of operations are based upon the financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of any contingent liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. On an on-going basis we review our estimates and assumptions. The estimates were based on historical experience and other assumptions that we believe to be reasonable under the circumstances. Actual results are likely to differ from those estimates under different assumptions or conditions, but we do not believe such differences will materially affect our financial position or results of operations.

In light of these risks and uncertainties, and especially given the nature of our existing and proposed business, there can be no assurance that the forward-looking statements contained in this section and elsewhere in this Quarterly Report on Form 10-Q will in fact occur. Potential investors should not place undue reliance on any forward- looking statements. Except as expressly required by the federal securities laws, there is no undertaking to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changed circumstances or any other reason.

The discussion and analysis of the financial condition and results of operations are based upon the financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of any contingent liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. On an on-going basis we review our estimates and assumptions. The estimates were based on historical experience and other assumptions that we believe to be reasonable under the circumstances. Actual results are likely to differ from those estimates under different assumptions or conditions, but we do not believe such differences will materially affect our financial position or results of operations.

Company Overview

Bionik Laboratories Corp. is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and innovative robotics technology and data solutions to help individuals from hospital to home to regain mobility, enhance autonomy, and regain self-esteem.

The Company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver greater recovery for patients with neurological or mobility impairments. These technologies allow large amounts of data to be collected and processed in real-time, enabling appropriately challenging and individualized therapy during every treatment session. This is the foundation of the InMotion® therapy. The Company’s rehabilitation therapy robots are built on an artificial intelligence platform, measuring the position, the speed and the acceleration of the patients’ arm 200 times per second. The artificial intelligence platform is designed to adapt in real time to the patient’s needs and progress while providing quantifiable feedback of a patient’s progress and performance, in a way that the Company believes a trained clinician cannot.

Based on this foundational work, the Company has a portfolio of products and solutions focused on upper and lower extremity rehabilitation for stroke and other mobility-impaired individuals, including three InMotion® robots currently in the market and two products in varying stages of development.

COVID-19

As a result of extended shutdowns of businesses around the world due to the COVID-19 pandemic, we have seen a slowdown in our business as most of the capital expenditure programs of the healthcare facilities that make up our customer base have been put on hold or has been significantly curtailed. This, along with our typically long sales cycle, has affected our ability to generate revenues in recent months. As a result, we have taken steps to address the decrease in revenue, as follows:

Effective April 1, 2020, we furloughed three employees in the United States and temporarily laid-off one employee in Canada. Additionally, our senior management agreed to a salary deferral of between 30-50%. Our remaining employees in the U.S. received base salary reductions of between 30%-50%. In Canada, our remaining employees received a reduction in base salary and hours of 45%. As a result of obtaining the U.S. and Canadian government’s programs described below, U.S. employees with salaries less than $100,000 annually were returned to full salary and with salaries exceeding $100,000 annually were increased to 75% of their normal base salary. Most of the Company’s Canadian and US employees have returned to their normal base salary. Senior management are continuing with the previously established salary deferrals.

On May 6, 2020, our U.S. subsidiary received funding in the original principal amount of $459,912 pursuant to the federal Paycheck Protection Program under the Coronavirus Aid, Relief and Economic Security Act, which is administered by the U.S. Small Business Administration. We are using the proceeds from this funding for eligible purposes, including to retain workers and maintain payroll or make mortgage interest payments, lease payments, and utility payments. The loan was funded by Bank of America, N.A. pursuant to the terms of a Promissory Note dated as of May 1, 2020. We intend to apply for forgiveness for all or a portion of the loans in accordance with applicable law.

Our Canada operations secured $37,612 of government financial relief under the Canadian Emergency Wage Subsidy, which is available monthly until December 2020 which was used to return the salaries of many of our Canadian employees back to their full amount.

The Company has reduced working on its research and development projects to focus only on the development of InMotion Connect^TM, to provide the ability for hospital management to access remotely to management dashboards presenting the utilization data of each of their InMotion® robotic devices and their InMotion® robotic devices productivity.

Recent Developments

On May 18, 2020, we terminated our Distribution Agreement dated May 17, 2017 with China Bionik Medical Rehabilitation Technology Ltd., and the related License Agreement dated May 17, 2017. The Distribution Agreement and the License Agreement were originally entered into as part of the Company’s cooperative joint venture in China evidenced by that Co-operative Joint Venture Contract dated May 17, 2017, as amended, made between the Company and Ginger Capital Investment Holding, Ltd. As a result of the termination of the Distribution Agreement and the License Agreement, we further gave notice to Ginger Capital that we were terminating the Co-operative Joint Venture Contract in accordance with its terms.

In September 2019, we commenced an up to $3 million convertible note offering (subsequently increased to $7,000,000), of which $1,302,575 was raised through June 30, 2020 and an additional approximately $200,000 was raised in July 2020. In addition, on March 23, 2020, we borrowed $2,000,000 evidenced by a term promissory note from an existing stockholder and lender of the Company.

History

Bionik Laboratories Corp. was incorporated on January 8, 2010 in the State of Colorado. At the time of our incorporation the name of our company was Strategic Dental Management Corp. On July 16, 2013, we changed our name from Strategic Dental Management Corp. to Drywave Technologies, Inc. and changed our state of incorporation from Colorado to Delaware. Effective February 13, 2015, we changed our name to Bionik Laboratories Corp.

Bionik Laboratories Inc. was incorporated on March 24, 2011 under the Canada Business Corporations Act.

On February 26, 2015, we entered into an Investment Agreement with Bionik Acquisition Inc., a company existing under the laws of Canada and our wholly owned subsidiary, and Bionik Canada whereby we acquired 100 Class 1 common shares of Bionik Canada representing 100% of the outstanding Class 1 common shares of Bionik Canada. After giving effect to this and related transactions, we commenced operations through Bionik Canada. Subsequently, on April 21, 2016, we acquired Interactive Motion Technologies, Inc., or IMT, a Boston, Massachusetts-based provider of effective robotic products for neurorehabilitation, including all its owned and licensed products both commercialized and in development.

Corporate Information

Our principal executive office is located at 483 Bay Street, N105, Toronto, ON, Canada M5G 2C9 and our main corporate telephone number is (416) 640-7887 x 508. Our principal US office is located at 80 Coolidge Hill Road, Watertown, MA, USA 02472, telephone number 617-926-4800. Our website is www.bioniklabs.com. Information on our website does not constitute a part of this Quarterly Report on Form 10-Q.

Our Business

The InMotion® therapy uses the Company’s robots to assist patients to rewire a segment of their brains after injury, also known as neuroplasticity. The InMotion® Robots - the InMotion® ARM, InMotion® WRIST and the InMotion® ARM/HAND – are designed to provide intelligent, adaptive therapy in a manner that has been clinically shown to maximize neurorecovery.

The Company commenced developing a next generation home version of the InMotion® upper-body rehabilitation technology, and may develop a lower-body wearable assistive product which is in technical development and based on the Company’s existing ARKE lower body exoskeleton technology, which could allow certain mobility impaired individuals to walk better. The Company intends to continue development of these new products as and when the Company has sufficient funds and resources. We may in the future further augment our product portfolio through technology acquisition opportunities should they become available and if we are sufficiently capitalized to undertake these investments.

The InMotion® ARM, InMotion® ARM/HAND, and InMotion® WRIST are robotic therapies for the upper limbs. InMotion® robotic therapies have been characterized as Class II medical devices by the U.S. Food and Drug Administration, or FDA, and are listed with the FDA to market and sell in the United States. More than 280 of our clinical robotic products for stroke rehabilitation have been sold in over 15 countries, including the United States. In addition to these fully developed, clinical rehabilitation solutions, we are also developing “InMotion HomeTM”, which is an upper extremity product that allows the patient to extend their therapy for as long as needed while rehabilitating at home. This rehabilitation solution is being developed on the same design platform as the InMotion® clinical products.

We believe recent payment changes in the U.S. marketplace proposed and finalized by the Centers for Medicare and Medicaid Services will create a favorable environment for greater clinical adoption of our robotic technology. For instance, the Improving Medicare Post-Acute Care Transformation Act of 2014, or the Impact Act of 2014, began the shift toward standardizing patient assessment data for quality measures. The updated Prospective Payment System (PPS), SNF QRP (Quality Reporting Program) and SNF VBP (Value Based Purchasing) programs have further shifted reimbursement toward the needs of the patient and away from volume of services provided in the skilled nursing setting. Other programs have caused a similar shift in the Inpatient Rehabilitation Facility setting, as well, resulting in such providers being publicly ranked, as well as financially rewarded, for quality reporting and better outcomes.

We have a growing body of clinical data for our products. More than 1,500 patients participated in trials using our InMotion® robots, the results of which have been published in peer-reviewed medical journals (including the New England Journal of Medicine and Stroke).

An earlier model of InMotion® robots were used in a multicenter randomized controlled phase III interventional trial, funded by the National Institute for Health Research Health Technology Assessment Program (RATULS) in the United Kingdom. The study was completed in 2018, included the enrollment of 770 stroke patients in a multi-center randomized controlled research trial to evaluate the clinical and cost effectiveness of robot-assisted training in post-stoke care. The RATULS trial confirmed the finding of previous research studies which demonstrated that robot assisted therapy improved upper limb impairment when compared with conventional care of stroke victims.

The primary outcome for upper limb success was determined by an Action Research Arm Test (ARAT), with four distinct success criteria that varied according to baseline severity. This test with these success criteria was developed by the RATULS trial team for this study and has not been used previously in clinical trials. The findings of this major research trial demonstrated that robot assisted therapy improved upper limb impairment, however, using this ARAT measurement, the trial was unable to conclude that robot assisted therapy or enhance upper limb therapy resulted in improved upper limb functionality after stroke compared with usual care provided to patients with stroke related upper limb functional limitation. The study findings also showed that the attrition rate was drastically reduced in the patient population following either robotic therapy or enhanced upper limb therapy versus usual care only. Most of the withdrawals from the study were before 3 months of usual care due to the disappointment with the treatment allocation.

We collaborated with Intelliware Development, a leading custom software solutions company based in Toronto, to customize and deploy a new software platform, InMotion Connect^TM. InMotion Connect^TM , launched in June 2020, is designed to target the critical need to link patient centric rehabilitation results to patient management portals. InMotion Connect^TM is providing the ability for hospital management to access remotely to management dashboards presenting the utilization data of each of their InMotion® robotic devices and their robotic devices’ productivity. Customized reporting capabilities in the platform focus on facility and organization measurement dashboards to support effective decision making for clinicians and for hospital management. Through further customization with each hospital system, patients progress during the therapy sessions and patient’s evaluation will be made available and ultimately feed electronic medical records (EMR) at any hospital or rehabilitation facility. We believe that leveraging Intelliware’s healthcare software development expertise will ensure the HL7 compliant InMotion Connect™ will seamlessly feed data through existing various hospital protocols, providing practitioners protected patient data and treatment results.

On December 14, 2018, we entered into a Sale of Goods Agreement (the “Agreement”) with CHC Management Services, LLC, or Kindred, pursuant to which, among other things, Kindred agreed to purchase from us in a first phase a minimum of 21 of the Company’s InMotion® ARM Interactive Therapy Systems – a minimum of one for each of Kindred’s existing and soon-to-open affiliated inpatient rehabilitation hospitals and similar facilities described in the Agreement, and in a second phase a minimum of one InMotion® ARM Interactive Therapy System for each future facilities of Kindred, during the four-year minimum term of the Agreement. 21 InMotion® robots were sold in total to Kindred by March 31, 2019.

We have also entered into an agreement with Cogmedix Inc., a wholly owned subsidiary of Coghlin Companies, a medical device development and manufacturing company located in West Boylston, MA, to produce InMotion® robots. The initial agreement is for turnkey, compliant manufacturing with the capability of scaling faster production to meet increased volume as the Company grows. In addition, our Massachusetts-based manufacturing facility is compliant with ISO- 13485 and FDA regulations.

We currently hold an intellectual property portfolio that includes 5 U.S. patents and 1 U.S. pending patent, 5 of which are pending internationally, as well as other patents under development. We may file provisional patents from time to time, which may expire if we do not pursue full patents within 12 months of the filing date. Two provisional patents have recently been filed, pertaining to BIONIK’s InMotion Home^TM development and recently launched InMotion Connect^TM platform, each of which the Company plans to file as a full patent prior to the 12-month deadline. The provisional patents may not be filed as full patents and new provisional patents may be filed as the technology changes. Additionally, we hold exclusive licenses to three additional patents of which one is currently being used for the InMotion® Wrist and is licensed to us from the Massachusetts Institute of Technology.

We have filed trademarks in the U.S. and European Union for InMotion®, InMotion Home™, InMotion Connect™, InMotion Pulse™, and InMotion Insights™; the trademark for InMotion® is registered in the European Union and in the U.S., the trademark for InMotion Connect is registered in the European Union and pending in the US, while InMotion Home™, InMotion Pulse™, and InMotion Insights™ are pending in both jurisdictions.

We currently sell our products directly or can introduce customers to a third-party finance company to lease at a monthly fee over the term or other fee structure for our products to hospitals, clinics, distribution companies and/or buying groups that supply those rehabilitation facilities.

We introduced our new enhanced commercial version of the InMotion® product line starting with the InMotion® ARM in December 2017 and then the InMotion® ARM/HAND in January 2019. We sold 11 InMotion® robots in the fiscal year ended March 31, 2018, 33 InMotion® robots in the fiscal year ended March 31, 2019, 17 InMotion® robots for the fiscal year ended March 31, 2020, and 2 robots in the three months ended June 30, 2020.

We had $257,908 of revenue for the first quarter ended June 30, 2020 compared to $790,379 for the first quarter ended June 30, 2019.

Significant Accounting Policies and Estimates

The discussion and analysis of the financial condition and results of operations are based upon the financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of any contingent liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. On an on-going basis we review our estimates and assumptions. The estimates were based on historical experience and other assumptions that we believe to be reasonable under the circumstances. Actual results are likely to differ from those estimates under different assumptions or conditions, but we do not believe such differences will materially affect our financial position or results of operations.

Results of Operations

From the inception of Bionik Canada on March 24, 2011 through June 30, 2020 we have generated a deficit of $73,380,946.

We expect to incur additional operating losses through the fiscal year ending March 31, 2021 and beyond, principally as a result of our continuing research and development, building the sales and marketing team, long sales cycles and general and administrative costs predominantly associated with being a public company.

For the Quarter ended June 30, 2020 compared to the Quarter ended June 30, 2019

Sales

Sales were $257,908 for the quarter ended June 30, 2020 (June 30, 2019 - $790,379). The revenues for the quarter ended June 30, 2020 are comprised of sales of 2 (June 30, 2019 – 8) InMotion™ robots, as well as service, and warranty income. The decrease in the number of InMotion™ robots sold is related to delays that impact on our business from the COVID-19 pandemic.

Cost of Sales and Gross Margin

Cost of sales was $62,555 for the quarter ended June 30, 2020 (June 30, 2019- $336,085). Gross margin increased to 75.7% for the quarter ended June 30, 2020 (June 30, 2019 – 57.5%) due to the reversal of an overstated warranty reserve of $81,224, and was 57.6% without the effects of the warranty adjustment.

Operating Expenses

Total operating expenses for the quarter ended June 30, 2020 were $2,153,889 compared to $2,622,989 for the quarter ended June 30, 2019, as further described below.

For the quarter ended June 30, 2020, the Company incurred $223,185 in sales and marketing expenses, compared to $583,732 for the quarter ended June 30, 2019. The decrease in these expenses is that due to the COVID-19 pandemic, the sales team has not been able to travel or go to conferences.

For the quarter ended June 30, 2020, the Company incurred research and development expenses of $353,263 (June 30, 2019– $816,523). The decrease in research and development expenses relates to a reduction in the employees in this department and the completion of the development of our InMotion Connect product.

The Company incurred general and administrative expenses of $1,128,510 for the quarter ended June 30, 2020, compared to $841,693 for the quarter ended June 30, 2019. The increase in general and administrative expenses in 2020 over 2019 resulted from legal fees and other public company related costs.

Stock compensation expense was $407,315 for the quarter ended June 30, 2020, compared to $287,757 for the quarter ended June 30, 2019, due to increased option grant expense in the period ended June 30, 2020 compared to the period ended June 30, 2019.

Amortization of technology and other assets allocated from the purchase of IMT was $23,504 for the quarter ended June 30, 2020 (June 30, 2019 – $69,314). The amortization has decreased as certain assets acquired have been fully amortized. Assets acquired were workforce and non-compete agreements which is now fully amortized. Customer relationships is amortized over 10 years, patents and our exclusive license agreements over their lifetime and trademarks are indefinite and therefore are not amortized.

Depreciation amounted to $18,112 for the quarter ended June 30, 2020 (June 30, 2019 -$23,970).

Other Expenses (Income)

For the quarter ended June 30, 2020, we incurred other expense of $74,975 (June 30, 2019 – $14,296). The increase in other expenses relates to higher interest expense in connection with higher indebtedness in the period ended June 30, 2020 compared to the period ended June 30, 2019.

For the quarter ended June 30, 2020, we received other income of $37,612 (June 30, 2019 - $Nil) from Canadian government grants relating to the COVID-19 pandemic, used for payroll in Canada (CEWS). CEWS is recognized as other income in the consolidated statement of operations in the period in which the Company recognizes expenses for which CEWS is intended to compensate.

For the quarter ended June 30, 2020, we incurred a foreign exchange loss of $11,177 (June 30, 2019 – ($62,357)). On April 1, 2015, our subsidiaries changed their functional currency from the Canadian Dollar to the U.S. Dollar. This reflects the fact that most of the Company’s business is influenced by an economic environment denominated in U.S. currency as well as that the Company anticipates revenues to be earned in U.S. dollars.

Comprehensive loss for the quarter ended June 30, 2020 was $(2,007,076), resulting in loss per share of $(0.39), and for the quarter ended June 30, 2019 the comprehensive loss was $(2,120,644), resulting in loss per share of ($0.55).

Liquidity and Capital Resources

We have funded operations through the issuance of capital stock, loans, grants, and investment tax credits received from the Government of Canada. Since 2015, we have raised an aggregate of $11,341,397 from the sale of our stock, incurred an aggregate of $27,613,608 in loans that were subsequently converted into our common stock, and incurred an aggregate of $400,000 in loans that were repaid in accordance with their terms. Additionally, in May 2020 we received funding of $459,912 pursuant to the federal Paycheck Protection Program under the Coronavirus Aid, Relief and Economic Security Act. The loan is unsecured, bears interest of 1% per annum and a deferment period of 6 months. The loan is to be used primarily for payroll related costs, lease, and utility payments. The Company intends to apply for forgiveness for all or a portion of the loans in accordance with applicable law. If the loan is not forgiven, the Company will be obligated to repay the loan during the period of 2 years.

In June 2020, the Company has received additional convertible loans of $1,302,575. At June 30, 2020, the Company had outstanding loans in the aggregate principal amount of $3,912,592.

Based on our current burn rate, we need to raise additional capital in the short term to fund operations and meet expected future liquidity requirements, as well as to repay our remaining existing indebtedness (including our funding from the CARES Act, if and to the extent the loan is not forgiven), or we will be required to curtail or terminate some or all of our product lines or our operations. We are continuously in discussions to raise additional capital, which may include or be a combination of convertible or term loans and equity which, if successful, will enable us to continue operations based on our current burn rate, for the next 12 months; however, we cannot give any assurance at this time that we will successfully raise all or some of such capital or any other capital. Furthermore, we do not have an established source of funds sufficient to cover operating costs after December 2020 at this time.

There can be no assurance that necessary debt or equity financing will be available, or will be available on terms acceptable to us, in which case we may be unable to meet our obligations or fully implement our business plan, if at all. These conditions raise substantial doubt about the Company's ability to continue as a going concern. The accompanying condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on recoverability and reclassification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.

Additionally, we will need additional funds to respond to business opportunities including potential acquisitions of complementary technologies, protect our intellectual property, develop new lines of business, and enhance our operating infrastructure. While we may need to seek additional funding for any such purposes, we may not be able to obtain financing on acceptable terms, or at all. In addition, the terms of our financings may be dilutive to, or otherwise adversely affect, holders of our common stock. We will also seek additional funds through arrangements with collaborators or other third parties. However, the recent COVID-19 pandemic has presented unprecedented challenges to businesses and the investing landscape around the world. Therefore, there can be no assurance that management’s plans will be successful. We may not be able to negotiate any such arrangements on acceptable terms, if at all. If we are unable to obtain additional funding on a timely basis, we may be required to curtail or terminate some or all of our product lines or our operations.

As a result of the COVID-19 pandemic and actions taken to slow its spread, the global credit and financial markets have experienced extreme volatility, including diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in unemployment rates and uncertainty about economic stability. There can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. If equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult to obtain, more costly and/or more dilutive. Any of these actions could materially harm our business, results of operations and future prospects.

Net Cash Used in Operating Activities

During quarter ended June 30, 2020, we used cash in operating activities of $(1,629,197). The increased use of cash in the quarter ended June 30, 2020, compared to a use of $(1,323,946) for the quarter ended June 30, 2019, is mainly attributable to the working capital changes in the quarter ended June 30, 2020.

Net Cash Used in Investing Activities

During the quarter ended June 30, 2020, net cash used in investing activities was $(Nil), compared to $(42,802) for the quarter ended June 30, 2019.

Net cash used in investing activities in the quarter ended June 30, 2019 was used for the acquisition of equipment related to the Company’s purchase of additional computer equipment due to the increase in engineers, equipment to help with the development of our technology and demo units to assist in the sales process.

Net Cash Provided by Financing Activities

Net cash provided by financing activities was $1,762,487 for the quarter ended June 30, 2020, compared to $1,450,000 for the quarter ended June 30, 2019. The increase in the quarter ended June 30, 2020 was due to more capital raised and PPP loan.

Newly Adopted and Recently Issued Accounting Pronouncements

In January 2017, the FASB issued ASU 2017-04, “Intangibles – Goodwill and Other”. ASU 2017-04 simplifies the accounting for goodwill impairment by eliminating Step 2 of the current goodwill impairment test, which required a hypothetical purchase price allocation.

Recently issued

Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying condensed consolidated interim financial statements.

Off-Balance Sheet Arrangements

We had no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not applicable for smaller reporting companies.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

We maintain “disclosure controls and procedures” as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

As of the end of the period covered by this Quarterly Report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Exchange Act Rules 13a-15(b) and 15d-15(b). Based upon this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures as of the end of the period covered by this Quarterly Report were effective.

Changes in Internal Control over Financial Reporting

During the three months ended June 30, 2020, there were no changes in our internal controls over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Part II- OTHER INFORMATION

Item 1. Legal Proceedings

None

Item 1A. Risk Factors

Not applicable for smaller reporting companies

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

All unregistered issuances of equity securities during the period covered by this quarterly report have been previously disclosed on our Current Reports on Form 8-K.

Item 3. Defaults Upon Senior Securities.

None

Item 4. Mine Safety Disclosures

Not applicable

Item 5. Other Information

None

(b) Exhibits

The following exhibits, which are numbered in accordance with Item 601 of Regulation S-K, are filed herewith or, as noted, incorporated by reference herein.

Exhibit

Number

Description of Exhibits

10.1

Promissory Note, dated May 1, 2020 (Incorporated by reference to the Company’s Current Report on Form 8-K filed on May 12, 2020)

10.2

Form of Subscription Agreement (Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 9, 2020)

10.3

Form of Promissory Note (Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 9, 2020)

10.4

Allonge to Convertible Promissory Note dated June 3, 2020 (Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 9, 2020)

31.1

Certificate of Chief Executive Officer as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Certificate of Chief Financial Officer as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

Certification of Chief Executive Officer as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2

Certification of Chief Financial Officer as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS

XBRL Instance Document

101.SCH

XBRL Taxonomy Extension Schema Document

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: August 12, 2020

	Bionik Laboratories Corp.

	By:	/s/ Eric Dusseux
		Eric Dusseux
		Chief Executive Officer
		(Principal Executive Officer)

		By: /s/ Leslie Markow Leslie Markow
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-31.1 2 tm2024627d1_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Eric Dusseux, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Bionik Laboratories Corp.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report, our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in case of an quarterly report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Date:August 12, 2020	/s/ Eric Dusseux
	Eric Dusseux
	Chief Executive Officer
	(Principal Executive Officer)

EX-31.2 3 tm2024627d1_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Leslie Markow, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Bionik Laboratories Corp.

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Date: August 12, 2020	/s/ Leslie Markow
	Leslie Markow
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

EX-32.1 4 tm2024627d1_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Bionik Laboratories Corp. (the "Company") on Form 10-Q for the quarterly period ended June 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Eric Dusseux, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: August 12, 2020	/s/ Eric Dusseux
	Eric Dusseux
	Chief Executive Officer
	(Principal Executive Officer)

EX-32.2 5 tm2024627d1_ex32-2.htm EXHIBIT 32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Bionik Laboratories Corp. (the "Company") on Form 10-Q for the quarterly period ended June 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Leslie Markow, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: August 12, 2020	/s/ Leslie Markow
	Leslie Markow
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

EX-101.INS 6 bnkl-20200630.xml XBRL INSTANCE DOCUMENT 0001508381 2018-10-29 2018-10-29 0001508381 2015-02-13 2015-02-13 0001508381 us-gaap:RetainedEarningsMember 2020-06-30 0001508381 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001508381 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001508381 us-gaap:RetainedEarningsMember 2020-03-31 0001508381 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001508381 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001508381 us-gaap:RetainedEarningsMember 2019-06-30 0001508381 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001508381 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001508381 us-gaap:RetainedEarningsMember 2019-03-31 0001508381 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001508381 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001508381 us-gaap:CommonStockMember 2020-06-30 0001508381 us-gaap:CommonStockMember 2020-06-30 0001508381 bnkl:SpecialVotingPreferredStockMember 2020-06-30 0001508381 bnkl:ExchangeableSharesMember 2020-06-30 0001508381 bnkl:CommonSharesAndExchangeableSharesMember 2020-06-30 0001508381 us-gaap:CommonStockMember 2020-03-31 0001508381 us-gaap:CommonStockMember 2020-03-31 0001508381 bnkl:SpecialVotingPreferredStockMember 2020-03-31 0001508381 bnkl:ExchangeableSharesMember 2020-03-31 0001508381 bnkl:CommonSharesAndExchangeableSharesMember 2020-03-31 0001508381 us-gaap:CommonStockMember 2019-06-30 0001508381 bnkl:SpecialVotingPreferredStockMember 2019-06-30 0001508381 us-gaap:CommonStockMember 2019-03-31 0001508381 us-gaap:CommonStockMember 2019-03-31 0001508381 bnkl:SpecialVotingPreferredStockMember 2019-03-31 0001508381 bnkl:ExchangeableSharesMember 2019-03-31 0001508381 bnkl:EmployeesVestEquallyOnJanuary242021Member 2018-01-24 2018-01-24 0001508381 bnkl:EmployeesVestEquallyOnJanuary242020Member 2018-01-24 2018-01-24 0001508381 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2018-01-24 2018-01-24 0001508381 bnkl:EmployeesVestEquallyOnJanuary242019Member 2018-01-24 2018-01-24 0001508381 bnkl:EmployeesMember 2020-04-01 2020-06-30 0001508381 bnkl:ShareBasedPaymentArrangementEmployeesAndConsultantsMember us-gaap:EmployeeStockOptionMember 2019-04-01 2020-03-31 0001508381 bnkl:EmployeesMember 2018-04-01 2019-03-31 0001508381 bnkl:StockOptionTwoMember 2020-06-30 0001508381 bnkl:StockOptionTwentyOneMember 2020-06-30 0001508381 bnkl:StockOptionTwentyMember 2020-06-30 0001508381 bnkl:StockOptionTwelveMember 2020-06-30 0001508381 bnkl:StockOptionThreeMember 2020-06-30 0001508381 bnkl:StockOptionThirteenMember 2020-06-30 0001508381 bnkl:StockOptionTenMember 2020-06-30 0001508381 bnkl:StockOptionSixteenMember 2020-06-30 0001508381 bnkl:StockOptionSixMember 2020-06-30 0001508381 bnkl:StockOptionSeventeenMember 2020-06-30 0001508381 bnkl:StockOptionSevenMember 2020-06-30 0001508381 bnkl:StockOptionOneMember 2020-06-30 0001508381 bnkl:StockOptionNineteenMember 2020-06-30 0001508381 bnkl:StockOptionNineMember 2020-06-30 0001508381 bnkl:StockOptionFourteenMember 2020-06-30 0001508381 bnkl:StockOptionFourMember 2020-06-30 0001508381 bnkl:StockOptionFiveMember 2020-06-30 0001508381 bnkl:StockOptionFifteenMember 2020-06-30 0001508381 bnkl:StockOptionElevenMember 2020-06-30 0001508381 bnkl:StockOptionEightMember 2020-06-30 0001508381 bnkl:StockOptionEighteenMember 2020-06-30 0001508381 bnkl:ShareBasedPaymentArrangementEmployeesAndConsultantsMember us-gaap:EmployeeStockOptionMember 2019-07-26 2019-07-26 0001508381 bnkl:DirectorAndEmployeesMember 2019-05-31 2019-05-31 0001508381 bnkl:ExecutiveEmployeeAndConsultantMember 2017-09-01 2017-09-01 0001508381 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:EmployeeStockOptionMember 2019-09-03 2019-09-03 0001508381 srt:MinimumMember bnkl:DirectorAndEmployeesMember 2019-05-31 2019-05-31 0001508381 srt:MaximumMember bnkl:DirectorAndEmployeesMember 2019-05-31 2019-05-31 0001508381 bnkl:ExecutiveEmployeeAndConsultantMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2017-09-01 2017-09-01 0001508381 2020-03-23 2020-03-23 0001508381 bnkl:SpecialVotingPreferredStockMember 2020-06-30 0001508381 bnkl:SpecialVotingPreferredStockMember 2020-03-31 0001508381 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001508381 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001508381 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001508381 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001508381 bnkl:SpecialVotingPreferredStockMember 2020-04-01 2020-06-30 0001508381 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001508381 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001508381 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001508381 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001508381 bnkl:SpecialVotingPreferredStockMember 2019-04-01 2019-06-30 0001508381 bnkl:ChinaBasedJointVentureMember 2017-05-17 0001508381 bnkl:ConvertibleLoansPayableMember 2020-03-31 0001508381 bnkl:ConvertibleLoansPayableMember 2019-04-01 2020-03-31 0001508381 us-gaap:TrademarksMember 2020-06-30 0001508381 us-gaap:NoncompeteAgreementsMember 2020-06-30 0001508381 us-gaap:CustomerRelationshipsMember 2020-06-30 0001508381 bnkl:PatentsAndExclusiveLicenseAgreementMember 2020-06-30 0001508381 bnkl:AssembledWorkforceMember 2020-06-30 0001508381 us-gaap:TrademarksMember 2020-03-31 0001508381 us-gaap:NoncompeteAgreementsMember 2020-03-31 0001508381 us-gaap:CustomerRelationshipsMember 2020-03-31 0001508381 bnkl:PatentsAndExclusiveLicenseAgreementMember 2020-03-31 0001508381 bnkl:AssembledWorkforceMember 2020-03-31 0001508381 bnkl:ChinaBasedJointVentureMember us-gaap:CoVenturerMember 2017-05-17 0001508381 bnkl:PromissoryNoteMember 2020-03-23 2020-03-23 0001508381 bnkl:PromissoryNoteMember 2020-05-01 0001508381 bnkl:ConvertibleLoansPayableWithConversionPriceTwoMember 2020-01-01 0001508381 bnkl:ConvertibleLoansPayableWithConversionPriceOneMember 2019-12-31 0001508381 bnkl:InventoryCostMember 2020-04-01 2020-06-30 0001508381 bnkl:InventoryCostMember 2019-04-01 2019-06-30 0001508381 us-gaap:SubsequentEventMember 2020-07-01 0001508381 bnkl:ConvertibleLoansPayableMember 2020-06-30 0001508381 bnkl:ExchangeableSharesMember 2020-04-01 2020-06-30 0001508381 bnkl:ExchangeableSharesMember 2019-04-01 2020-03-31 0001508381 2018-06-12 0001508381 2017-11-06 0001508381 2017-03-31 0001508381 2014-12-31 0001508381 bnkl:WarrantTwoMember 2020-06-30 0001508381 bnkl:WarrantOneMember 2020-06-30 0001508381 bnkl:Warrant3Member 2020-06-30 0001508381 2019-06-30 0001508381 2018-03-31 0001508381 bnkl:InteractiveMotionTechnologiesIncMember 2016-04-21 2016-04-21 0001508381 us-gaap:NoncompeteAgreementsMember 2020-04-01 2020-06-30 0001508381 us-gaap:CustomerRelationshipsMember 2020-04-01 2020-06-30 0001508381 bnkl:PatentsAndExclusiveLicenseAgreementMember 2020-04-01 2020-06-30 0001508381 bnkl:AssembledWorkforceMember 2020-04-01 2020-06-30 0001508381 us-gaap:TrademarksMember 2019-04-01 2020-03-31 0001508381 us-gaap:NoncompeteAgreementsMember 2019-04-01 2020-03-31 0001508381 us-gaap:CustomerRelationshipsMember 2019-04-01 2020-03-31 0001508381 bnkl:PatentsAndExclusiveLicenseAgreementMember 2019-04-01 2020-03-31 0001508381 bnkl:AssembledWorkforceMember 2019-04-01 2020-03-31 0001508381 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:EmployeeStockOptionMember 2020-04-01 2020-06-30 0001508381 bnkl:ShareBasedPaymentArrangementEmployeesAndConsultantsMember us-gaap:EmployeeStockOptionMember 2020-04-01 2020-06-30 0001508381 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2020-04-01 2020-06-30 0001508381 us-gaap:EmployeeStockOptionMember 2020-04-01 2020-06-30 0001508381 bnkl:ExecutiveEmployeeAndConsultantMember 2020-04-01 2020-06-30 0001508381 bnkl:DirectorAndEmployeesMember 2020-04-01 2020-06-30 0001508381 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2019-04-01 2019-06-30 0001508381 us-gaap:EmployeeStockOptionMember 2019-04-01 2019-06-30 0001508381 bnkl:ExecutiveEmployeeAndConsultantMember 2019-04-01 2019-06-30 0001508381 us-gaap:ToolsDiesAndMoldsMember 2020-06-30 0001508381 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2020-06-30 0001508381 us-gaap:FurnitureAndFixturesMember 2020-06-30 0001508381 us-gaap:ComputerEquipmentMember 2020-06-30 0001508381 bnkl:ManufacturingEquipmentMember 2020-06-30 0001508381 bnkl:DemonstrationEquipmentMember 2020-06-30 0001508381 us-gaap:ToolsDiesAndMoldsMember 2020-03-31 0001508381 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2020-03-31 0001508381 us-gaap:FurnitureAndFixturesMember 2020-03-31 0001508381 us-gaap:ComputerEquipmentMember 2020-03-31 0001508381 bnkl:ManufacturingEquipmentMember 2020-03-31 0001508381 bnkl:DemonstrationEquipmentMember 2020-03-31 0001508381 srt:ChiefFinancialOfficerMember 2020-06-30 0001508381 srt:ChiefExecutiveOfficerMember 2020-06-30 0001508381 bnkl:ChiefCommercialOfficerMember 2020-06-30 0001508381 srt:ChiefFinancialOfficerMember 2020-03-31 0001508381 srt:ChiefExecutiveOfficerMember 2020-03-31 0001508381 bnkl:ChiefCommercialOfficerMember 2020-03-31 0001508381 2020-08-12 0001508381 bnkl:FormerChiefTechnologyOfficerAndNewChiefTechnologyOfficerMember 2015-02-25 2015-02-25 0001508381 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001508381 us-gaap:CommonStockMember 2019-04-01 2020-03-31 0001508381 bnkl:ShareExchangeAgreementMember 2015-02-26 2015-02-26 0001508381 2019-03-31 0001508381 bnkl:StockOptionTwoMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionTwentyOneMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionTwentyMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionTwelveMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionThreeMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionThirteenMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionTenMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionSixteenMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionSixMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionSeventeenMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionSevenMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionOneMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionNineteenMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionNineMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionFourteenMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionFourMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionFiveMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionFifteenMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionElevenMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionEightMember 2020-04-01 2020-06-30 0001508381 bnkl:StockOptionEighteenMember 2020-04-01 2020-06-30 0001508381 2019-04-01 2020-03-31 0001508381 2019-04-01 2019-06-30 0001508381 bnkl:PromissoryNoteMember 2020-05-01 2020-05-01 0001508381 2015-02-25 2015-02-25 0001508381 bnkl:ChiefTechnologyOfficerMember 2020-06-30 0001508381 bnkl:ChiefTechnologyOfficerMember 2020-03-31 0001508381 us-gaap:TrademarksMember 2020-04-01 2020-06-30 0001508381 bnkl:ConvertibleLoansPayableMember 2020-04-01 2020-06-30 0001508381 2020-06-30 0001508381 2020-03-31 0001508381 bnkl:WarrantTwoMember 2020-04-01 2020-06-30 0001508381 bnkl:WarrantOneMember 2020-04-01 2020-06-30 0001508381 bnkl:Warrant3Member 2020-04-01 2020-06-30 0001508381 2020-04-01 2020-06-30 0001508381 us-gaap:RetainedEarningsMember 2019-07-01 2020-03-31 0001508381 us-gaap:CommonStockMember 2019-07-01 2020-03-31 0001508381 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2020-03-31 0001508381 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2020-03-31 0001508381 bnkl:SpecialVotingPreferredStockMember 2019-07-01 2020-03-31 0001508381 2019-07-01 2020-03-31 iso4217:USD xbrli:shares xbrli:pure xbrli:shares iso4217:USD 0 0 0 0 0 0 0 6 <div> <div> Canada Emergency Wage Subsidy (CEWS) CEWS is recognized as other income in the consolidated statement of operations in the period in which the Company recognizes expenses for which CEWS is intended to compensate. <div /></div> </div> 2022-03-31 2023-03-31 2022-08-14 117683 117683 <div> <div> Unaudited Condensed Consolidated Interim Financial Statements These unaudited condensed consolidated interim financial statements have been prepared on the same basis as the annual audited financial statements of the Company and should be read in conjunction with those annual audited financial statements filed on Form 10‑K for the year ended March 31, 2020. The interim disclosures generally do not repeat those in the annual statements. In the opinion of management, these unaudited condensed consolidated interim financial statements reflect all adjustments necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods shown. The results of operations for such periods are not necessarily indicative of the results expected for a full year or for any future period. The changes in accounting policies in the Company’s unaudited condensed consolidated interim financial statements from the March 31, 2020 audited financial statements are described below. <div /></div> </div> 5000000 0.20 Indefinite 0.02 0.02 241185 P6M 0.01 0 459912 <div> <div> 5.     PREPAID EXPENSES AND OTHER RECEIVABLES   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30,  </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Prepaid expenses and other receivables </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 34,272 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 78,816 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Prepaid inventory </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,499,042 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,450,024 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Prepaid insurance </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 176,928 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 57,226 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Sales taxes receivable (i) </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 13,111 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 46,489 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,723,353 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,632,555 </td> </tr> </table></div> <div><hr style="border-width:0;width:25%;height:1pt;color:#000;background-color:#000;" align="left"></hr></div>i)Sales tax receivable represents net harmonized sales taxes (HST) input tax credits receivable from the Government of Canada.<div /></div> </div> 78816 34272 1450024 1499042 0 459912 <div> <div> Recently issued Accounting Standards Update 2020-06—Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity: simplifies accounting for convertible instruments by removing major separation models required under current Generally Accepted Accounting Principles (GAAP). Consequently, more convertible debt instruments will be reported as a single liability instrument and more convertible preferred stock as a single equity instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU also simplifies the diluted earnings per share (EPS) calculation in certain areas. The amendments in this Update are effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is assessing the impact that the adoption of ASU 2020-06 will have on the consolidated balance sheet and consolidated statement of operations. <div /></div> </div> P2Y 790379 257908 <div> <div> The following is a summary of common share purchase warrants outstanding as of June 30, 2020.   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercise  </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of  </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Price ($) </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Warrants </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Expiry Date </td> </tr> <tr> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 90.00 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 15,658 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> March 31, 2023 </td> </tr> <tr> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 9.375 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 64,025 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> August 14, 2022 </td> </tr> <tr> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 9.375 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 42,684 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> March 31, 2022 </td> </tr> <tr> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 122,367 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> </table></div>   <div /></div> </div> <div> <div> The following is a continuity schedule of the Company’s common share purchase warrants:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted </td> </tr> <tr> <td valign="bottom" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Average </td> </tr> <tr> <td valign="bottom" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercise Price  </td> </tr> <tr> <td valign="bottom" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">  Warrants </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> ($) </td> </tr> <tr> <td valign="top" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding and exercisable, March 31, 2019 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 288,517 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 40.27 </td> </tr> <tr> <td valign="top" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Expired </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (163,483) </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (38.91) </td> </tr> <tr> <td valign="top" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding and exercisable, March 31, 2020 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 125,034 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 20.07 </td> </tr> <tr> <td valign="top" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Expired </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (2,667) </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (37.50) </td> </tr> <tr> <td valign="top" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding and exercisable June 30, 2020 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 122,367 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 19.69 </td> </tr> </table></div>   <div /></div> </div> 38.91 37.50 2028-04-19 2024-02-06 2024-03-03 2024-09-30 2022-12-14 2022-11-24 2024-09-30 2024-02-13 2026-05-31 2021-06-20 2023-03-28 2025-01-24 2023-03-28 2027-09-01 2024-03-03 2024-03-14 2022-02-17 2024-03-14 2026-07-26 2026-09-03 2021-07-01 40.27 20.07 19.69 3.14 <div> <div> 12.     WARRANTS The following is a continuity schedule of the Company’s common share purchase warrants:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted </td> </tr> <tr> <td valign="bottom" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Average </td> </tr> <tr> <td valign="bottom" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercise Price  </td> </tr> <tr> <td valign="bottom" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">  Warrants </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> ($) </td> </tr> <tr> <td valign="top" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding and exercisable, March 31, 2019 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 288,517 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 40.27 </td> </tr> <tr> <td valign="top" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Expired </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (163,483) </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (38.91) </td> </tr> <tr> <td valign="top" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding and exercisable, March 31, 2020 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 125,034 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 20.07 </td> </tr> <tr> <td valign="top" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Expired </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (2,667) </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (37.50) </td> </tr> <tr> <td valign="top" style="width:68.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding and exercisable June 30, 2020 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 122,367 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 19.69 </td> </tr> </table></div>   During the quarter ended June 30, 2020, 2,667 warrants expired in accordance with their terms. Common share purchase warrants The following is a summary of common share purchase warrants outstanding as of June 30, 2020.   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercise  </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of  </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Price ($) </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Warrants </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Expiry Date </td> </tr> <tr> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 90.00 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 15,658 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> March 31, 2023 </td> </tr> <tr> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 9.375 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 64,025 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> August 14, 2022 </td> </tr> <tr> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 9.375 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 42,684 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> March 31, 2022 </td> </tr> <tr> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 122,367 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:31.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> </table></div>   The weighted-average remaining contractual term of the outstanding warrants was 2.07. <div /></div> </div> 1268191 0 79116 6 0 1268 0 0 0 2134 2098 626923 931222 false --03-31 Q1 2020 2020-06-30 10-Q 0001508381 5009151 Yes false Non-accelerated Filer Yes Bionik Laboratories Corp. false true BNKL

857093

443874

9464

30866

1827

32472

57246

193285

70963

846964

975272

1647656

2057784

444714

37662

86688

264520

30953

17264

7627

462826

49395

86789

269174

31240

18415

7813

42149

84643570

85050885

-1726320

-1483170

57259

287757

28554

50755

57259

407315

28554

269579

1168

167500

69314

277258

134090

143168

23504

20277

3227

18516620

18713745

5826568

6065309

157667

<div> <div> The schedule below reflects the intangible assets acquired in the IMT acquisition and the assets amortization period and expense for the three months ended June 30, 2020, and the year ended March 31, 2020:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value  </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Impairment </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Expenses </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value at </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Expenses </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value at </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Amortization </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> acquired </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, 2020 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, 2020 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30, 2020 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30, 2020 </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Intangible assets acquired </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> period (years) </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Patents and exclusive License Agreement </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:9pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9.74 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,306,031 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 307,388 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:9pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>134,090 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 469,962 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 20,277 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 449,685 </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Trademark </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Indefinite </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,505,907 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,605,907 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 900,000 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 900,000 </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Customer relationships </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:9pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,431,680 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 787,245 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:9pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>143,168 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 79,962 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,227 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 76,735 </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Non compete agreement </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:9pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 61,366 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Assembled workforce </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:9pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 275,720 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,580,704 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,700,540 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-weight:bold;color:#000000;font-family:Times New Roman,Times,serif;font-size:9pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>277,258 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,449,924 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 23,504 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,426,420 </td> </tr> </table></div>   <div /></div> </div>

446779

2269747

530031

2269747

2403037

83252

133290

9.375

90.00

9.375

122367

42684

15658

64025

<div> <div> 13.     COMMITMENTS AND CONTINGENCIES Contingencies From time to time, the Company may be involved in a variety of claims, suits, investigations and proceedings arising in the ordinary course of our business, collections claims, breach of contract claims, labor and employment claims, tax and other matters. Although claims, suits, investigations and proceedings are inherently uncertain and their results cannot be predicted with certainty, the Company believes that the resolution of current pending matters will not have a material adverse effect on its business, financial position, results of operations or cash flow. Regardless of the outcome, litigation can have an adverse impact on the Company because of legal costs, diversion of management resources and other factors. Commitments (a)On February 25, 2015, 1,753 common shares were issued to two former lenders connected with a $241,185 loan received and repaid during fiscal 2013. The common shares were valued at $210,323 based on the value of the concurrent private placement and recorded in stock-based compensation on the consolidated statement of operations and comprehensive loss. As part of the consideration for the initial loan, the Company's then-CTO and COO had transferred 2,098 common shares to the lenders. For contributing the common shares to the lenders, the Company intends to reimburse the former CTO and COO 2,134 common shares. As at June 30, 2020 these shares have not yet been issued. (b)On May 17, 2017, the Company entered into a Co-operative Joint Venture Contract (the “JV Contract”) with Ginger Capital Investment Holding, Ltd. (the “JV Partner”) to form  China Bionik Medical Rehabilitation Technology Ltd. (“China JV”), pursuant to which, among other things, the Company was to have a 25% interest and the JV Partner  a 75% interest. The Company applied the equity method of accounting to the joint venture. The Company gave notice on May 18, 2020 to the JV Partner of the termination of the China JV as well as terminating the Licensing and Distribution agreements with the China JV. As a result of the termination of the China JV and related commercial agreements, the Company has been communicating with its counterparts regarding such termination.   (c)In connection with the acquisition of IMT, the Company acquired a license agreement dated June 8, 2009, with a former director as a co-licenser, pursuant to which the Company pays the director and the co-licenser an aggregate royalty of 1% of sales based on patent #8,613,691. No sales have been made, as the technology under this patent has not been commercialized. <div /></div> </div>

0.001

200000000

150000000

250000000

500000000

5009151

5126

-2120644

-2007076

616063

582281

79116

70000

200000

2078833

3452680

336085

299795

62555

143810

<div> <div> 8.     NOTES PAYABLE (a) Convertible Loans Payable During the quarter ended June 30, 2020, the Company received $1,302,575, in addition to $70,000 previously loaned to the Company, pursuant to a $3,000,000 (later increased to $7,000,000) convertible note offering. The convertible notes bear interest at a fixed rate at 1% per month. The convertible loans will be convertible into equity of the Company upon the following events on the following terms: <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:0pt;"></td><td valign="top" align="left" style="width: 18.00pt;"> (i) </td><td style="width:0pt;"></td><td align="left" valign="top"> On the Maturity Date, the outstanding principal and accrued and unpaid interest under the convertible note will be converted into shares of common stock at a conversion price of $8.55 per shares in the event of an investment on or prior to December  31, 2019, and $9.50 per share in the event of an investment after December  31, 2019 (the “Conversion Price”).</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:0pt;"></td><td valign="top" align="left" style="width: 18.00pt;"> (ii) </td><td style="width:0pt;"></td><td align="left" valign="top"> Upon a change of control transaction prior to the Maturity Date, the outstanding principal and accrued and unpaid interest under the convertible notes would, at the election of the holders of a majority of the outstanding principal of the loans under the offering, be either (i) payable upon demand as of the closing of such change of control transaction or (ii) convertible into shares of the Company’s common stock immediately prior to such change of control transaction at a price per share equal to the lesser of (x) the Conversion Price or (y) the per share consideration to be received by the holders of the common stock in such change of control transaction.</td></tr></table></div> In the event the Company raises capital through the sale of Common Stock for cash during the period ending on the three year anniversary of the issuance date of the convertible notes, and the price per share thereof (the “Offering Price”) minus 20% is less than the original Conversion Price, then in such event the Company shall issue to all convertible loan holder at, at no further cost, additional shares of common stock equal to the number of conversion shares the holders would have received upon conversion if the Conversion Price equaled to a 20% discount to the Offering Price, less the number of shares of conversion shares actually issued on or as of the Maturity Date. Since the Company has early adopted ASU 2017-11, the anti-dilution protection clause does not contribute to the conversion feature to be a derivative liability. The interest accrued on these convertible loans for the period ended June 30, 2020 was $15,588 (March 31, 2020- $4,317). (b) Short term loan On March 23, 2020, the Company received a $2,000,000 loan from an existing shareholder. The promissory note bears interest at a fixed rate of 1% per month and has a maturity date of the earlier of (i) March 31, 2022 and (ii) the date of receipt of a minimum of US$5,000,000 from a “Subsequent Financing.” The accrued interest shall be payable one-half at the maturity date, and one-half on a quarterly basis as follows: (a) the quarterly interest payments shall be payable in cash commencing on the six month anniversary of the issue date (or the nine month anniversary of the issue date if as of such six month anniversary the World Health Organization (or a corresponding government or government agency) still categorizes or deems COVID-19 or the novel corona virus as a pandemic or outbreak) (the “First Interest Payment Date”), with the quarterly payments accruing for the first (or first two, as the case may be) interest payment dates nevertheless being payable, without further interest thereon, pro rata from the First Interest Payment Date through the maturity date. The loan is repayable or convertible to common shares at the loan holder’s option. Interest accrued on this loan at June 30, 2020 is $64,516(March 31, 2020- $4,516).   (c) PPP Loan   On May 1, 2020, the Company signed a Promissory Note for $459,912 pursuant to the federal Paycheck Protection Program under the Coronavirus Aid, Relief and Economic Security Act, which is administered by the U.S. Small Business Administration. The loan is unsecured, bears interest of 1% per annum and a deferment period of 6 months. The loan is to be used primarily for payroll related costs, lease and utility payments. The Company intends to apply for forgiveness for all or a portion of the loans in accordance with applicable law. If the loan is not forgiven, the Company will be obligated to repay the loan during the period of 2 years.   <div /></div> </div>

8.55

9.50

459912

0.01

23970

18112

<div> <div> 11.     STOCK OPTIONS The purpose of the Company’s equity incentive plan, is to attract, retain and motivate persons of training, experience and leadership to the Company, including their directors, officers and employees, and to advance the interests of the Company by providing such persons with the opportunity, through share options, to acquire an increased proprietary interest in the Company. On September 1, 2017, the Company granted 81,436 options at $24.15 per share equally to an executive officer and a consultant, who is now the Chairman of the Company. 27,148 options have vested and 50% of the remaining options vest on performance being met and 50% vest annually over 5 years for the CEO, for our Chairman the options vest over 5 years. The grant date fair value was $1,832,304 and $57,259 is the current expense for the quarter ended June 30, 2020 (June 30, 2019 - $57,259). On January 24, 2018, the Company granted 24,267 options at $23.25 per share to employees that vest equally on January 24, 2019, 2020 and 2021.  7,334 options were cancelled for the year ended March 31, 2019 and 266 for the three-month period ended June 30, 2020. The grant fair value was $491,036 and $28,554 is the current stock compensation expense for the quarter ended June 30, 2020 (June 30, 2019 - $28,554). On May 31, 2019 169,882 options were issued to employees and directors of the Company with an exercise price of $3.16 per share that vest over 1 year and 6 months, of which one-third immediately vest and one-third vest over each of the next two 6-month periods. The options expire in 7 years. The options were valued using the Black Scholes model and the following inputs were used: expected life of 7 years, expected volatility of 114% and a risk-free rate of 1.59%. The grant fair value was $453,585 and $50,755 of stock compensation was recognized for the quarter ended June 30, 2020. On July 26, 2019, 484,612 options were granted to employees and consultants at an exercise price of $3.595. The options were using the Black Scholes model and the following inputs were used: expected life of 7 years, expected volatility of 114% and a risk-free rate of 1.59%. The grant fair value was $1,525,525. 11,461 options were cancelled for the year ended March 31, 2020 and 1,286 were canceled and stock compensation of $269,579 was recognized in the quarter ended June 30, 2020. On September 3, 2019, 5,000 options were granted to an employee at an exercise price of $3.20 which will vest over three years starting September 3, 2020. The options were valued using the Black Scholes model and the following inputs were used: expected life of 7 years, expected volatility of 114% and a risk-free rate of 1.59%. The grant fair value was $14,010 and $1,168 of stock compensation expense was recognized in the quarter ended June 30, 2020. During the quarter ended June 30, 2020, the Company recorded $407,315  in share-based compensation related to the vesting of stock options (June 30, 2019 – $287,757). The following is a summary of stock options outstanding and exercisable as of June 30, 2020:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercise Price ($) </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of Options </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Expiry Date </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercisable Options </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 34.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 630 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 20-Jun-21 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 630 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 34.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 13,212 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 01-Jul-21 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 13,212 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 34.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 944 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 17-Feb-22 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 944 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 183.000 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,667 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 24-Nov-22 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,667 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 150.000 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 11,400 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 14-Dec-22 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 11,400 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 142.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 359 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 28-Mar-23 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 359 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 157.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,387 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 28-Mar-23 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,387 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 105.000 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,667 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 06-Feb-24 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,667 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 102.000 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,667 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 13-Feb-24 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,667 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 142.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 106 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 03-Mar-24 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 106 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 157.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 408 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 03-Mar-24 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 408 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 142.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 43 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 14-Mar-24 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 43 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 157.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 164 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 14-Mar-24 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 164 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 142.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 327 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 30-Sep-24 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 327 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 157.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,264 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 30-Sep-24 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,264 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 24.150 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 81,436 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 01-Sep-27 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 40,722 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 23.250 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 13,064 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 24-Jan-25 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 9,132 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 9.735 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 40,000 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 19-Apr-28 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 40,000 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3.16 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 168,283 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 31-May-26 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 168,283 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3.595 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 473,151 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 26-July-26 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 56,417 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3.20 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5,000 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 03-Sep-26 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 818,179 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 351,798 </td> </tr> </table></div>   The weighted-average remaining contractual term of the outstanding options is 6.02 years (March 31, 2020 – 6.28 years) and for the options that are exercisable the weighted average is 5.84 years (March 31, 2020 – 6.12 years). <div /></div> </div>

17840

18657

17840

18657

-0.55

-0.39

0.75

1430240

1453744

P1Y

P9Y8M27D

P10Y

P2Y

62347

-11177

841693

1128510

11085984

454294

195353

2700540

307388

787245

1605907

-93835

-413219

-496181

128308

472

-41434

406425

58016

-33782

483

817

176376

-114472

-160305

90798

<div> <div> <a name="_Hlk16032736"></a><a name="_contentSection_ea34ce52_a59a_477f_b054_"></a>4.     TECHNOLOGY AND OTHER ASSETS The schedule below reflects the intangible assets acquired in the IMT acquisition and the assets amortization period and expense for the three months ended June 30, 2020, and the year ended March 31, 2020:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value  </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Impairment </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Expenses </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value at </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Expenses </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value at </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Amortization </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> acquired </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, 2020 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, 2020 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30, 2020 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30, 2020 </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Intangible assets acquired </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> period (years) </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Patents and exclusive License Agreement </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:9pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9.74 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,306,031 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 307,388 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:9pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>134,090 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 469,962 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 20,277 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 449,685 </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Trademark </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Indefinite </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,505,907 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,605,907 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 900,000 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 900,000 </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Customer relationships </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:9pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,431,680 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 787,245 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:9pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>143,168 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 79,962 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,227 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 76,735 </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Non compete agreement </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:9pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 61,366 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Assembled workforce </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:9pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 275,720 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:20.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,580,704 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,700,540 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-weight:bold;color:#000000;font-family:Times New Roman,Times,serif;font-size:9pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>277,258 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,449,924 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 23,504 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,426,420 </td> </tr> </table></div>   The cumulative amortization for the technology and other assets  was $1,453,744 at June 30, 2020 (March 31, 2020- $1,430,240). <div /></div> </div>

1449924

469962

79962

900000

1426420

449685

76735

900000

4317

15588

-13283

-74975

4516

64516

<div> <div> 6.     INVENTORIES   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:71.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:71.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30,  </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:71.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:71.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> </tr> <tr> <td valign="bottom" style="width:71.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:71.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Finished Goods </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 944,990 </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,059,462 </td> </tr> </table></div>   During the three-month period ended June 30, 2020, the Company expensed $143,810 in inventory as cost of goods sold (June 30, 2019 - $299,795) offset by a warranty adjustment of $81,224. The Company no longer maintains a raw materials inventory as it has outsourced its manufacturing to a third party. <div /></div> </div>

1059462

944990

1059462

944990

18516620

18713745

5199645

6996531

3000000

7000000

0.25

<div> <div> <a name="_Hlk16032721"></a>2.     BASIS OF PRESENTATION During the 2019 fiscal year, holders of the common stock and exchangeable shares of the Company approved, through a majority shareholder vote, an amendment to the Company’s Amended and Restated Certificate of Incorporation authorizing the Board of Directors to effect a reverse stock split of Bionik’s common stock and exchangeable shares at a ratio up to one-to-one hundred and fifty. The preparation of these consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ materially from those estimates. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of June 30, 2020 and through the date of this report filing.   <div /></div> </div>

1450000

1762487

-42802

-1323946

-1629197

-2120644

-22895853

-2007076

<div> <div> Newly Adopted and Recently Issued Accounting Pronouncements Newly Adopted In January 2017, the FASB issued ASU 2017-01, “Business Combinations: Clarifying the definition of a Business” which amends the current definition of a business. Under ASU 2017-01, to be considered a business, an acquisition would have to include an input and a substantive process that together significantly contributes to the ability to create outputs. ASU 2017-01 further states that when substantially all of the fair value of gross assets acquired is concentrated in a single asset (or a group of similar assets), the assets acquired would not represent a business. The new guidance also narrows the definition of the term “outputs” to be consistent with how it is described in Topic 606, Revenue from Contracts with Customers. The changes to the definition of a business will likely result in more acquisitions being accounted for as asset acquisitions. ASU 2017-01 is effective for acquisitions commencing on or after December 31, 2019, with early adoption permitted. Adoption of this guidance will be applied prospectively on or after the effective date and the Company does not expect this policy will have a material effect on the consolidated balance sheet or consolidated statement of cash flows. In January 2017, the FASB issued ASU 2017-04, “Intangibles – Goodwill and Other” ASU 2017-04 simplifies the accounting for goodwill impairment by eliminating Step 2 of the current goodwill impairment test, which required a hypothetical purchase price allocation. Goodwill impairment will now be the amount by which the reporting unit’s carrying value exceeds its fair value, limited to the carrying value of the goodwill. ASU 2017-04 is effective for financial statements issued for fiscal years, and interim periods beginning after December 15, 2019. The Company has adopted ASU 2017-04 and it did not have a material effect on the consolidated balance sheet and consolidated statement of operations. In June 2016, the FASB issued ASU 2016-13 Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments, which introduces an expected credit loss methodology for the impairment of financial assets measured at amortized cost basis. The methodology replaces the probable, incurred loss model for those assets. The update if effective for fiscal years beginning after December 15, 2019. The Company has adopted ASU 2016-13 and it did not have a material effect on the consolidated balance sheet and consolidated statement of operations. <div /></div> </div>

5580704

275720

1306031

1431680

61366

2505907

2622989

2153889

<div> <div> 1.     NATURE OF OPERATIONS AND GOING CONCERN The Company and its Operations Bionik Laboratories Corp. (the “Company” or “Bionik”) was incorporated on January 8, 2010 in the State of Colorado as Strategic Dental Management Corp. On July 16, 2013, the Company changed its name to Drywave Technologies Inc. (“Drywave”)  and its state of incorporation from Colorado to Delaware. Effective February 13, 2015, the Company changed its name to Bionik Laboratories Corp. and reduced the authorized number of shares of common stock from 200,000,000 to 150,000,000. Concurrently, the Company implemented a 1-for-0.831105 reverse stock split of the common stock, which had previously been approved on September 24, 2014. On October 29, 2018, the Company implemented at 1 for 150 reverse stock-split of the common and exchangeable shares. On February 26, 2015, the Company entered into a Share Exchange Agreement and related transactions whereby it acquired Bionik Laboratories Inc., a Canadian Corporation (“Bionik Canada”) and Bionik Canada issued 333,334 Exchangeable Shares, representing a 3.14 exchange ratio, for 100% of the then outstanding common shares of Bionik Canada (the “Merger”). The Exchangeable Shares are exchangeable at the option of the holder, each into one share of the common stock of the Company. In addition, the Company issued one Special Preferred Voting Share (the “Special Preferred Share”) (Note 10). On April 21, 2016, the Company acquired all of the outstanding shares and, accordingly, all assets and liabilities of Interactive Motion Technologies, Inc. (IMT), a Boston, Massachusetts-based global pioneer and leader in providing effective robotic products for neurorehabilitation, pursuant to an Agreement and Plan of Merger (the “Merger Agreement”) dated March 1, 2016, with IMT, Hermano Igo Krebs, and Bionik Mergerco Inc., a Massachusetts corporation and the Company’s wholly owned subsidiary (Bionik Mergerco). The merger agreement provided for the merger of Bionik Mergerco with and into IMT, with IMT surviving the merger as the Company’s wholly owned subsidiary. In return for acquiring IMT, IMT shareholders received an aggregate of 157,667 shares of the Company’s common stock (Note 4). On November 6, 2017, the Company approved an increase in its authorized shares of common stock to 250,000,000 from 150,000,000, and on June 12, 2018, the Company approved an increase in its authorized shares of common stock to 500,000,000 from 250,000,000. References to the Company refer to the Company and its wholly owned subsidiaries, Bionik Inc., Bionik Acquisition Inc. and Bionik Canada. The Company is a global pioneering robotics company focused on providing rehabilitation solutions to individuals with neurological disorders, specializing in designing, developing and commercializing cost-effective physical rehabilitation technologies, prosthetics, and assisted robotic products. The Company strives to innovate and build devices that can rehabilitate and improve an individual’s health, comfort, accessibility and quality of life through the use of advanced algorithms and sensing technologies that anticipate a user’s every move. These unaudited condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), which contemplates continuation of the Company as a going concern, which assumes the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The Company’s principal offices are located at 483 Bay Street, N105, Toronto, Ontario, Canada M5G 2C9 and its U.S. address is 80 Coolidge Hill Road, Watertown, MA 02472. Going Concern As at June 30, 2020, the Company had a working capital deficit of $931,222 (March 31, 2020 - working capital of $626,923) and an accumulated deficit of $(73,380,946) (March 31, 2020 $(71,373,870)) and the Company incurred a net loss and comprehensive loss of $(2,007,076) for the three month period ended June 30, 2020 (June 30, 2019 – $(2,120,644). There is no certainty that the Company will be successful in generating sufficient cash flow from operations or achieving and maintaining profitable operations in the future to enable it to meet its obligations as they come due and consequently continue as a going concern. The Company will require additional financing to fund its operations and it is currently working on securing this funding through corporate collaborations, public or private equity offerings or debt financings. Sales of additional equity securities by the Company would result in the dilution of the interests of existing stockholders. There can be no assurance that financing will be available when required. In the event that the necessary additional financing is not obtained, the Company would reduce its discretionary overhead costs substantially or otherwise curtail operations. The Company expects to raise additional funds to meet the Company’s anticipated cash requirements for the next 12 months; however, these conditions raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments to reflect the possible future effects on recoverability and reclassification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty. All adjustments, consisting only of normal recurring items, considered necessary for fair presentation have been included in these consolidated financial statements. <div /></div> </div>

14296

74975

48051

-48540

37612

42802

0.001

10000000

1632555

1723353

1632555

1723353

57226

176928

46489

13111

950000

1302575

500000

2000000

162449

81225

81224

26911

81224

2120644

2007076

<div> <div> 7.     EQUIPMENT Equipment consisted of the following as at June 30, 2020 and March 31, 2020:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:28.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30, 2020 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:28.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, 2020 </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Accumulated </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Accumulated </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Cost </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Depreciation </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Net </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Cost </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Depreciation </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Net </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Computers and electronics </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 303,337 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 269,174 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 34,163 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 303,337 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 264,520 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 38,817 </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Furniture and fixtures </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 36,795 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 31,240 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,555 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 36,795 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 30,953 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,842 </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Demonstration equipment </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 135,543 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 49,395 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 86,148 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 135,543 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 37,662 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 97,881 </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Manufacturing equipment </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 88,742 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 86,789 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,953 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 88,742 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 86,688 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,054 </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Tools and parts </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 11,422 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,813 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,609 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 11,422 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,627 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,795 </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Assets under capital lease </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 23,019 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 18,415 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,604 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 23,019 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 17,264 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,755 </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 598,858 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 462,826 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 136,032 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 598,858 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 444,714 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 154,144 </td> </tr> </table></div>   Equipment is recorded at cost less accumulated depreciation. Depreciation expense during the three-month period ended June 30, 2020 was $18,112  (June 30, 2019 - $23,970). <div /></div> </div>

598858

135543

88742

303337

36795

23019

11422

598858

135543

88742

303337

36795

23019

11422

154144

97881

2054

38817

5842

5755

3795

136032

86148

1953

34163

5555

4604

3609

<div> <div> Equipment consisted of the following as at June 30, 2020 and March 31, 2020:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:28.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30, 2020 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:28.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, 2020 </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Accumulated </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Accumulated </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Cost </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Depreciation </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Net </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Cost </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Depreciation </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Net </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Computers and electronics </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 303,337 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 269,174 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 34,163 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 303,337 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 264,520 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 38,817 </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Furniture and fixtures </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 36,795 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 31,240 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,555 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 36,795 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 30,953 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,842 </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Demonstration equipment </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 135,543 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 49,395 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 86,148 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 135,543 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 37,662 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 97,881 </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Manufacturing equipment </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 88,742 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 86,789 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,953 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 88,742 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 86,688 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,054 </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Tools and parts </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 11,422 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,813 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,609 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 11,422 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,627 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,795 </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Assets under capital lease </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 23,019 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 18,415 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,604 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 23,019 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 17,264 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,755 </td> </tr> <tr> <td valign="bottom" style="width:40.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 598,858 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 462,826 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 136,032 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 598,858 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 444,714 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 154,144 </td> </tr> </table></div>   <div /></div> </div>

<div> <div> 9.     RELATED PARTY TRANSACTIONS AND BALANCES (a)  Due from related parties At June 30, 2020 there was an outstanding loan to the Chief Technology Officer (“CTO”) of the Company of 18,657(March 31, 2020 – $17,840).The loan has an Interest rate of 2% based on the Canada Revenue Agency’s prescribed rate for such advances and is denominated in Canadian dollars. During the period ended June 30, 2020, the Company accrued interest receivable in the amount of $90 (March 31, 2020 – $472); the remaining fluctuation in the balance from the prior year is due to changes in foreign exchange. (b)  Accounts payable and accrued liabilities As at June 30, 2020, $193,285 (March 31, 2020 – $30,866 ) was owing to the CEO of the Company; $57,246 (March 31, 2020 – $9,464) was owing to the Chief Technology Officer; $70,963 (March 31, 2020 – $1,827  )was owing to the Chief Financial Officer (“CFO”), $32,472 (March 31, 2020 - $Nil) was owing to the Chief Commercial Officer (“CCO”), all related to bonuses and business expenses. <div /></div> </div>

816523

353263

-71373870

-73380946

<div> <div> <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:71.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:71.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30,  </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:71.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:71.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> </tr> <tr> <td valign="bottom" style="width:71.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:71.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Finished Goods </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 944,990 </td> <td valign="bottom" style="width:02.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,059,462 </td> </tr> </table></div>   <div /></div> </div>

<div> <div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:19.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30, 2020 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:19.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, 2020 </td> </tr> <tr> <td valign="bottom" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> shares </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> shares </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Exchangeable Shares </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance beginning of  period </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 117,683 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 118 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 196,799 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 197 </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Converted into common shares (a) </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (79,116) </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (79) </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at end of period </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 117,683 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 118 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 117,683 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 118 </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Common Shares </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at beginning of the period </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,009,151 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,008 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,661,838 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,661 </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Shares issued to exchangeable shareholders (a) </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 79,116 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 79 </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Shares issued on conversion of loans </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,268,191 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,268 </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Share consolidation rounding adjustment </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  6 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at end of the period </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,009,151 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,008 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,009,151 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,008 </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> TOTAL SHARES </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5,126,834 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5,126 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5,126,834 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5,126 </td> </tr> </table></div> <div><hr style="border-width:0;width:25%;height:1pt;color:#000;background-color:#000;" align="left"></hr></div>   (a)During the quarter ended June 30, 2020, Nil exchangeable shares were exchanged for common shares on a 1 for 1 basis in accordance with their terms. (March 31, 2020 – 79,116 shares)   <div /></div> </div>

583732

223185

287757

407315

P5Y

P1Y6M

P6M

P3Y

0.5

P2Y26D

P7Y

1.14

0.0159

163483

2667

288517

125034

122367

351798

40000

2667

408

1264

11400

2667

327

1667

168283

630

1387

9132

359

40722

106

164

944

56417

13212

P6Y1M13D

P5Y10M2D

7334

11461

266

1286

81436

24267

484612

5000

818179

40000

2667

408

1264

11400

2667

327

1667

168283

630

1387

13064

359

81436

106

164

944

473151

5000

13212

9.735

105.000

157.500

150.000

183.000

142.500

102.000

3.16

34.500

157.500

23.250

142.500

24.150

142.500

157.500

34.500

142.500

3.595

3.20

34.500

P6Y3M11D

P6Y7D

1832304

491036

453585

1525525

14010

27148

169882

24.15

23.25

3.16

3.595

3.20

<div> <div> The following is a summary of stock options outstanding and exercisable as of June 30, 2020:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercise Price ($) </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of Options </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Expiry Date </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercisable Options </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 34.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 630 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 20-Jun-21 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 630 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 34.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 13,212 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 01-Jul-21 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 13,212 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 34.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 944 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 17-Feb-22 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 944 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 183.000 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,667 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 24-Nov-22 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,667 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 150.000 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 11,400 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 14-Dec-22 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 11,400 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 142.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 359 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 28-Mar-23 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 359 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 157.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,387 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 28-Mar-23 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,387 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 105.000 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,667 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 06-Feb-24 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,667 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 102.000 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,667 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 13-Feb-24 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,667 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 142.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 106 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 03-Mar-24 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 106 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 157.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 408 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 03-Mar-24 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 408 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 142.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 43 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 14-Mar-24 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 43 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 157.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 164 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 14-Mar-24 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 164 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 142.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 327 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 30-Sep-24 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 327 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 157.500 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,264 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 30-Sep-24 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,264 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 24.150 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 81,436 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 01-Sep-27 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 40,722 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 23.250 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 13,064 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 24-Jan-25 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 9,132 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 9.735 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 40,000 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 19-Apr-28 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 40,000 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3.16 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 168,283 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 31-May-26 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 168,283 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3.595 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 473,151 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 26-July-26 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 56,417 </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3.20 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5,000 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 03-Sep-26 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 818,179 </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:23.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 351,798 </td> </tr> </table></div>   <div /></div> </div>

196799

3661838

3858637

3838637

5126834

117683

5009151

5126834

117683

5009151

5126834

<div> <div> <a name="_Hlk16032716"></a>Warranty Reserve and Deferred Warranty Revenue The Company provides a one-year warranty as part of its normal sales offering. When products are sold, the Company provides warranty reserves, which, based on the historical experience of the Company are sufficient to cover warranty claims. Accrued warranty reserves are included in accrued liabilities on the condensed consolidated interim balance sheets and amounted to $81,225 at June 30, 2020 (March 31, 2020 - $162,449). The Company also sells extended warranties for additional periods beyond the standard warranty. Extended warranty revenue is deferred and recognized as revenue over the extended warranty period. The Company recognized $Nil of expenses related to warranty expenses. Additionally, the Company reversed $81,224 of its warranty provision due to low warranty claims and recorded this expense and reversal in cost of goods sold for the three-month period ended June 30, 2020 (June 30, 2019 – $26,911). <div /></div> </div>

27407933

197

42149

73719299

3661

3858

-46357373

25575046

42149

74007056

3858

-48478017

13316975

5126

118

42149

84643570

5008

5126

-71373870

11717214

5126

118

42149

85050885

5008

5126

-73380946

<div> <div> 10.     SHARE CAPITAL<a name="_666907"></a>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:19.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30, 2020 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:19.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, 2020 </td> </tr> <tr> <td valign="bottom" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> shares </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> shares </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> $ </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Exchangeable Shares </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance beginning of  period </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 117,683 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 118 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 196,799 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 197 </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Converted into common shares (a) </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (79,116) </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (79) </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at end of period </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 117,683 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 118 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 117,683 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 118 </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Common Shares </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at beginning of the period </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,009,151 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,008 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,661,838 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,661 </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Shares issued to exchangeable shareholders (a) </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 79,116 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 79 </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Shares issued on conversion of loans </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,268,191 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,268 </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Share consolidation rounding adjustment </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  6 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at end of the period </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,009,151 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,008 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,009,151 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,008 </td> </tr> <tr> <td valign="top" style="width:58.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> TOTAL SHARES </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5,126,834 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5,126 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5,126,834 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5,126 </td> </tr> </table></div> <div><hr style="border-width:0;width:25%;height:1pt;color:#000;background-color:#000;" align="left"></hr></div>   (a)During the quarter ended June 30, 2020, Nil exchangeable shares were exchanged for common shares on a 1 for 1 basis in accordance with their terms. (March 31, 2020 – 79,116 shares)   Special Voting Preferred Share In connection with the Merger (Note 1), on February 26, 2015, the Company entered into a voting and exchange trust agreement (the “Trust Agreement”). Pursuant to the Trust Agreement, the Company issued one Special Voting Preferred Share to the Trustee, and the parties created a trust for the Trustee to hold the Special Voting Preferred Share for the benefit of the holders of the Exchangeable Shares (the “Beneficiaries”). Pursuant to the Trust Agreement, the Beneficiaries will have voting rights in the Company equivalent to what they would have had, had they received shares of common stock in the same amount as the Exchangeable Shares held by the Beneficiaries. In connection with the Merger and the Trust Agreement, effective February 20, 2015, the Company filed a certificate of designation of the Special Voting Preferred Share (the “Special Voting Certificate of Designation”) with the Delaware Secretary of State. Pursuant to the Special Voting Certificate of Designation, one share of the Company’s blank check preferred stock was designated as Special Voting Preferred Share. The Special Voting Preferred Share entitles the Trustee to exercise the number of votes equal to the number of Exchangeable Shares outstanding on a one-for-one basis during the term of the Trust Agreement. The Special Voting Preferred Share is not entitled to receive any dividends or to receive any assets of the Company upon liquidation and is not convertible into shares of common stock of the Company. The voting rights of the Special Voting Preferred Share will terminate pursuant to and in accordance with the Trust Agreement and the Special Voting Preferred Share will be automatically cancelled. <div /></div> </div>

0.831105

0.0067

79116

1268191

1753

333334

9143927

9142659

1268

210323

287757

1493855

407315

287757

407315

<div> <div> 14.     SUBSEQUENT EVENTS (a)Subsequent to June 30, 2020, the Company received an additional $200,000 from lenders under the terms of the convertible loans described in Note 8 (a). <div /></div> </div>

3858637

5126834

EX-101.SCH 7 bnkl-20200630.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - Condensed Consolidated Interim Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Condensed Consolidated Interim Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Condensed Consolidated Interim Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - PREPAID EXPENSES AND OTHER RECEIVABLES (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - EQUIPMENT - Schedule of net equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Condensed Consolidated Interim Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Condensed Consolidated Interim Statements of Changes in Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - NATURE OF OPERATIONS AND GOING CONCERN (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - BASIS OF PRESENTATION (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - TECHNOLOGY AND OTHER ASSETS - Intangible assets acquired (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - TECHNOLOGY AND OTHER ASSETS - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - INVENTORIES- Schedule of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - INVENTORIES - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - EQUIPMENT - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - NOTES PAYABLE - Short term loan (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - SHARE CAPITAL - Common shares issued (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - SHARE CAPITAL - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - STOCK OPTIONS - Summary of stock options outstanding and exercisable (Details) link:presentationLink link:calculationLink link:definitionLink 41102 - Disclosure - STOCK OPTIONS - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - WARRANTS - Summary of continuity schedule (Details) link:presentationLink link:calculationLink link:definitionLink 41202 - Disclosure - WARRANTS - Summary of common share purchase warrants outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 41203 - Disclosure - WARRANTS - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 41401 - Disclosure - SUBSEQUENT EVENTS - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - NATURE OF OPERATIONS AND GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - TECHNOLOGY AND OTHER ASSETS link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - PREPAID EXPENSES AND OTHER RECEIVABLES link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - SHARE CAPITAL link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - STOCK OPTIONS link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - WARRANTS link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 11401 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 20302 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - TECHNOLOGY AND OTHER ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - PREPAID EXPENSES AND OTHER RECEIVABLES (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - SHARE CAPITAL (Tables) link:presentationLink link:calculationLink link:definitionLink 31103 - Disclosure - STOCK OPTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 31203 - Disclosure - WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 bnkl-20200630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 bnkl-20200630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 bnkl-20200630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Information [Table] Document Information [Line Items] Document Type Amendment Flag Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Trading Symbol Entity Common Stock, Shares Outstanding Entity Emerging Growth Company Entity Shell Company Entity Small Business Condensed Consolidated Interim Balance Sheets Statement [Table] Statement [Line Items] TECHNOLOGY AND OTHER ASSETS Assets [Abstract] Assets Assets, Current [Abstract] Current Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents, end of the period Cash and cash equivalents, beginning of the period Cash and cash equivalents Accounts Receivable, Net, Current Accounts receivable, net of allowance for doubtful accounts of $Nil (March 31, 2020 - $167,500) Prepaid Expense and Other Assets, Current Prepaid expenses and other receivables (Note 5) Inventory, Net Inventories (Note 6) Due from Related Parties, Current Due from related parties (Note 9(a)) Assets, Current Total Current Assets Property, Plant and Equipment, Net Equipment, Net Equipment (Note 7) Intangible Assets, Net (Excluding Goodwill) Technology and other assets (Note 4) Goodwill Goodwill (Note 3) Assets Total Assets Liabilities and Equity [Abstract] Liabilities and Shareholders' Equity Liabilities, Current [Abstract] Current Accounts Payable, Current Accounts Payable (Notes 9(b)) Accrued Liabilities, Current Accrued liabilities (Notes 8 and 9(b)) Amount of PPP loan. Ppp Loan PPP Loan (Note 8 (c)) Convertible Notes Payable, Current Convertible Loans (Note 8(a) (b)) Deferred Revenue, Current Deferred revenue - Contract Liabilities Liabilities, Current Total Current Liabilities Stockholders' Equity Attributable to Parent [Abstract] Shareholders' Equity Preferred Stock, Value, Issued Preferred Stock, par value $0.001; Authorized 10,000,000 Special Voting Preferred Stock, par value $0.001; Authorized; Issued and outstanding - 1 (March 31, 2020 - 1) Common Stock, Value, Issued Common Shares, par value $0.001; Authorized - 500,000,000; Issued and outstanding 5,009,151 and 117,683 Exchangeable Shares (March 31, 2020 5,009,151 and 117,683 Exchangeable Shares) Additional Paid in Capital Additional paid in capital Retained Earnings (Accumulated Deficit) Deficit Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income Stockholders' Equity Attributable to Parent Closing Balance Opening Balance Total Shareholders' Equity Liabilities and Equity Total Liabilities and Shareholders' Equity Class of Stock [Axis] Class Of Stock [Domain] Class of Stock [Domain] Pertaining to the special voting preferred stock. Special Voting Preferred Stock [Member] Special Voting [Member] Allowance for Doubtful Accounts Receivable, Current Preferred Stock, Par or Stated Value Per Share Preferred Stock, Par Value (in dollars per share) Preferred Stock, Shares Authorized Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Total number of shares issued of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized. Common Stock, Other Shares, Issued Condensed Consolidated Interim Statements of Operations and Comprehensive Loss Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Sale Revenue Net Sales Cost of Goods and Services Sold Cost of Sales Gross Profit Gross Margin Operating Costs and Expenses [Abstract] Operating expenses Selling and Marketing Expense Sales and marketing Research and Development Expense Research and development General and Administrative Expense General and administrative Share-based Compensation Share-based compensation expense (Notes 11) Amortization of Intangible Assets Amortization Amortization (Note 4) Depreciation Depreciation (Note 7) Depreciation Operating Expenses Total operating expenses Other Income and Expenses [Abstract] Other (income) expenses Other Nonoperating Expense Other expense Other Operating Income Other income Foreign Currency Transaction Gain (Loss), before Tax Foreign exchange Other Nonoperating Income (Expense) Total other income (expenses) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive Income (Loss), Net of Tax Net loss and comprehensive loss for the period Earnings Per Share, Basic and Diluted Loss per share - basic and diluted Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted average number of shares outstanding - basic and diluted Condensed Consolidated Interim Statements of Changes in Shareholders' Equity Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock [Member] Common Shares [Member] Additional Paid In Capital [Member] Additional Paid in Capital [Member] Retained Earnings [Member] Deficit [Member] Accumulated Other Comprehensive Income [Member] Comprehensive Income [Member] Shares, Outstanding Closing Balance (in shares) Opening Balance (in shares) Stock Issued During Period, Value, Share-based Compensation, Gross Share compensation expense Stock Issued During Period, Shares, Share-based Compensation, Gross Share compensation expense (in shares) Stock Issued During Period, Value, Conversion of Convertible Securities Conversion of Promissory Note Shares issued to exchangeable shareholders (a) Stock Issued During Period, Shares, Conversion of Convertible Securities Conversion of Promissory Note (in shares) Shares issued to exchangeable shareholders (in shares) Net Income (Loss) Attributable to Parent Net loss for the year Amount of adjustments made due to share consolidation round up. Adjustments Due To Share Consolidation Round Up Adjustment due to 1:150 share consolidation round-up The total value of shares for adjustment due to share consolidation round up. Adjustments Due To Share Consolidation Round Up Shares Adjustment due to 1:150 share consolidation round-up (in shares) Condensed Consolidated Interim Statements of Cash Flows Net Cash Provided by (Used in) Operating Activities [Abstract] Operating activities Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss for the period Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustment for items not affecting cash Interest Income (Expense), Net Interest expense Stock or Unit Option Plan Expense Share based compensation expense Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities Increase (Decrease) in Operating Capital [Abstract] Changes in non-cash working capital items Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Prepaid Expenses, Other Prepaid expenses and other receivables Increase (Decrease) in Due from Related Parties Due from related parties Increase (Decrease) in Inventories Inventories Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accrued Liabilities Accrued liabilities Increase (Decrease) in Deferred Revenue Deferred revenue Net Cash Provided by (Used in) Operating Activities Net cash (used in) operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Investing activities Payments to Acquire Machinery and Equipment Acquisition of equipment Net Cash Provided by (Used in) Investing Activities Net cash (used in) investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Financing activities Proceeds from Convertible Debt Proceeds from convertible loans The cash inflow from PPP Loan. Proceeds From Ppp Loan Proceeds from PPP Loan Proceeds from term Debt Proceeds from short term loan Proceeds from term loan Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash and Cash Equivalents, Period Increase (Decrease) Net increase in cash and cash equivalents for the period NATURE OF OPERATIONS AND GOING CONCERN Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] NATURE OF OPERATIONS AND GOING CONCERN No definition available. BASIS OF PRESENTATION Nature of Operations [Text Block] BASIS OF PRESENTATION SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] SIGNIFICANT ACCOUNTING POLICIES TECHNOLOGY AND OTHER ASSETS Intangible Assets Disclosure [Text Block] TECHNOLOGY AND OTHER ASSETS PREPAID EXPENSES AND OTHER RECEIVABLES The entire disclosure for prepaid expenses and other receivables. Prepaid Expense And Other Receivables [Text Block] PREPAID EXPENSES AND OTHER RECEIVABLES INVENTORIES Inventory Disclosure [Text Block] INVENTORIES EQUIPMENT Property, Plant and Equipment Disclosure [Text Block] EQUIPMENT NOTES PAYABLE Debt Disclosure [Text Block] NOTES PAYABLE RELATED PARTY TRANSACTIONS AND BALANCES Related Party Transactions Disclosure [Text Block] RELATED PARTY TRANSACTIONS AND BALANCES SHARE CAPITAL Stockholders' Equity Note Disclosure [Text Block] SHARE CAPITAL STOCK OPTIONS Disclosure of Compensation Related Costs, Share-based Payments [Text Block] STOCK OPTIONS WARRANTS The entire disclosure for purchase of Warrants during the period. Shareholders Equity And Share Based Payments Stock Warrant [Text Block] WARRANTS COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES SUBSEQUENT EVENTS Subsequent Events [Text Block] SUBSEQUENT EVENTS Disclosure of accounting policy for reporting unaudited condensed consolidated interim financial statements accounting period. Consolidated Financial Statements [Policy Text Block] Unaudited Condensed Consolidated Interim Financial Statements New Accounting Pronouncements, Policy [Policy Text Block] Newly Adopted and Recently Issued Accounting Pronouncements It represents recently adopted accounting pronouncements policy text block. Recently Adopted Accounting Pronouncements Policy [Text Block] Recently Issued Disclosure of accounting policy Canada Emergency Wage Subsidy . Canada Emergency Wage Subsidy [Policy Text Block] Canada Emergency Wage Subsidy (CEWS) Standard Product Warranty, Policy [Policy Text Block] Warranty Reserve and Deferred Warranty Revenue Business Acquisition, Pro Forma Information [Table Text Block] Schedule of intangible assets acquired in the IMT acquisition Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Schedule of prepaid expenses and other receivables Schedule of Inventory, Current [Table Text Block] Schedule of inventory Property, Plant and Equipment [Table Text Block] Schedule of components of equipment Schedule of Stockholders Equity [Table Text Block] Schedule of share capital Share-based Compensation, Performance Shares Award Outstanding Activity [Table Text Block] Schedule of stock options outstanding and exercisable Tabular disclosure of the Stock purchase of Warrants Activity during the reporting period. Schedule Of Share Based Compensation Stock Purchase Warrants Activity [Table Text Block] Schedule of continuity schedule Tabular disclosure Common Share Purchase Warrants outstanding. Schedule of Common Share Purchase Warrants Outstanding [Table Text Block] Schedule of common share purchase warrants outstanding Registration Payment Arrangement by Arrangement [Axis] Registration Payment Arrangement Arrangement [Domain] Registration Payment Arrangement, Arrangement [Domain] Share Exchange Agreement [Member] Share Exchange Agreement [Member] Legal Entity [Axis] Entity [Domain] Entity [Domain] Interactive Motion Technologies Inc [Member] Interactive Motion Technologies, Inc. [Member] Stockholders' Equity Note, Stock Split, Conversion Ratio Reverse stock split ratio Stock Issued During Period, Shares, New Issues Ratio of exchangeable shares to then outstanding common shares. Share Exchange Ratio Exchange ratio of exchangeable shares to common shares outstanding Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Amount of working capital surplus (deficit) for relevant time periods. Working Capital Surplus Deficit Working Capital Surplus Standard and Extended Product Warranty Accrual Product Warranty Expense Warranty adjustment Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties Reversal of warranty provision Finite-Lived Intangible Assets by Major Class [Axis] Finite Lived Intangible Assets Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Patents And Exclusive License Agreement [Member] Patents and Exclusive License Agreement [Member] Trademarks [Member] Trademark [Member] Customer Relationships [Member] Customer Relationships [Member] Noncompete Agreements [Member] Non compete Agreement [Member] Assembled Workforce [Member] Assembled Workforce [Member] Finite-Lived Intangible Asset, Useful Life Finite lived intangible asset useful life description. Finite Lived Intangible Asset Useful Life Description Noncash or Part Noncash Acquisition, Intangible Assets Acquired Impairment of Intangible Assets (Excluding Goodwill) Finite-Lived Intangible Assets, Accumulated Amortization Technology and other assets cumulative amortization Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of sundry receivables. Prepaid Expenses and Sundry Receivables Prepaid expenses and other receivables Amount of asset related to consideration paid in advance for inventory that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Prepaid Inventory Prepaid inventory EX-101.PRE 11 bnkl-20200630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Jun. 30, 2020	Aug. 12, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Entity Registrant Name	Bionik Laboratories Corp.
Entity Central Index Key	0001508381
Current Fiscal Year End Date	--03-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Trading Symbol	BNKL
Entity Common Stock, Shares Outstanding		5,009,151
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Small Business	true

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Interim Balance Sheets - USD ($)	Jun. 30, 2020	Mar. 31, 2020
Current
Cash and cash equivalents	$ 2,403,037	$ 2,269,747
Accounts receivable, net of allowance for doubtful accounts of $Nil (March 31, 2020 - $167,500)	975,272	846,964
Prepaid expenses and other receivables (Note 5)	1,723,353	1,632,555
Inventories (Note 6)	944,990	1,059,462
Due from related parties (Note 9(a))	18,657	17,840
Total Current Assets	6,065,309	5,826,568
Equipment (Note 7)	136,032	154,144
Technology and other assets (Note 4)	1,426,420	1,449,924
Goodwill (Note 3)	11,085,984	11,085,984
Total Assets	18,713,745	18,516,620
Current
Accounts Payable (Notes 9(b))	443,874	857,093
Accrued liabilities (Notes 8 and 9(b))	2,057,784	1,647,656
PPP Loan (Note 8 (c))	459,912	0
Convertible Loans (Note 8(a) (b))	3,452,680	2,078,833
Deferred revenue - Contract Liabilities	582,281	616,063
Total Current Liabilities	6,996,531	5,199,645
Shareholders' Equity
Preferred Stock, par value $0.001; Authorized 10,000,000 Special Voting Preferred Stock, par value $0.001; Authorized; Issued and outstanding - 1 (March 31, 2020 - 1)	0	0
Common Shares, par value $0.001; Authorized - 500,000,000; Issued and outstanding 5,009,151 and 117,683 Exchangeable Shares (March 31, 2020 5,009,151 and 117,683 Exchangeable Shares)	5,126	5,126
Additional paid in capital	85,050,885	84,643,570
Deficit	(73,380,946)	(71,373,870)
Accumulated other comprehensive income	42,149	42,149
Total Shareholders' Equity	11,717,214	13,316,975
Total Liabilities and Shareholders' Equity	$ 18,713,745	$ 18,516,620

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Interim Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2020	Mar. 31, 2020
Allowance for Doubtful Accounts Receivable, Current	$ 0	$ 167,500
Preferred Stock, Par Value (in dollars per share)	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares, Issued	5,009,151	5,009,151
Common Stock, Shares, Outstanding	5,009,151	5,009,151
Common Stock, Other Shares, Issued	117,683	117,683
Special Voting [Member]
Preferred Stock, Par Value (in dollars per share)	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	1	1
Preferred Stock, Shares Issued	1	1
Preferred Stock, Shares Outstanding	1	1

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Interim Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss
Sales	$ 257,908	$ 790,379
Cost of Sales	62,555	336,085
Gross Margin	195,353	454,294
Operating expenses
Sales and marketing	223,185	583,732
Research and development	353,263	816,523
General and administrative	1,128,510	841,693
Share-based compensation expense (Notes 11)	407,315	287,757
Amortization (Note 4)	23,504	69,314
Depreciation (Note 7)	18,112	23,970
Total operating expenses	2,153,889	2,622,989
Other (income) expenses
Other expense	74,975	14,296
Other income	(37,612)	0
Foreign exchange	11,177	(62,347)
Total other income (expenses)	48,540	(48,051)
Net loss and comprehensive loss for the period	$ (2,007,076)	$ (2,120,644)
Loss per share - basic and diluted	$ (0.39)	$ (0.55)
Weighted average number of shares outstanding - basic and diluted	5,126,834	3,858,637

XML 16 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Interim Statements of Changes in Shareholders' Equity - USD ($)	Special Voting [Member]	Common Shares [Member]	Additional Paid in Capital [Member]	Deficit [Member]	Comprehensive Income [Member]	Total
Opening Balance at Mar. 31, 2019	$ 0	$ 3,858	$ 73,719,299	$ (46,357,373)	$ 42,149	$ 27,407,933
Opening Balance (in shares) at Mar. 31, 2019	1	3,858,637
Share compensation expense	$ 0	$ 0	287,757	0	0	287,757
Share compensation expense (in shares)	0	0
Net loss for the year	$ 0	$ 0	0	(2,120,644)	0	(2,120,644)
Closing Balance at Jun. 30, 2019	$ 0	$ 3,858	74,007,056	(48,478,017)	42,149	25,575,046
Closing Balance (in shares) at Jun. 30, 2019	1	3,838,637
Opening Balance at Mar. 31, 2019	$ 0	$ 3,858	73,719,299	(46,357,373)	42,149	27,407,933
Opening Balance (in shares) at Mar. 31, 2019	1	3,858,637
Closing Balance at Mar. 31, 2020	$ 0	$ 5,126	84,643,570	(71,373,870)	42,149	13,316,975
Closing Balance (in shares) at Mar. 31, 2020	1	5,126,834
Opening Balance at Jun. 30, 2019	$ 0	$ 3,858	74,007,056	(48,478,017)	42,149	25,575,046
Opening Balance (in shares) at Jun. 30, 2019	1	3,838,637
Share compensation expense	$ 0	$ 0	1,493,855	0	0	1,493,855
Share compensation expense (in shares)	0	0
Conversion of Promissory Note	$ 0	$ 1,268	9,142,659	0	0	9,143,927
Conversion of Promissory Note (in shares)	0	1,268,191
Net loss for the year	$ 0	$ 0	0	(22,895,853)	0	(22,895,853)
Adjustment due to 1:150 share consolidation round-up	$ 0	$ 0	0	0	0	0
Adjustment due to 1:150 share consolidation round-up (in shares)	0	6
Closing Balance at Mar. 31, 2020	$ 0	$ 5,126	84,643,570	(71,373,870)	42,149	13,316,975
Closing Balance (in shares) at Mar. 31, 2020	1	5,126,834
Share compensation expense	$ 0	$ 0	407,315	0	0	407,315
Net loss for the year	0	0	0	(2,007,076)	0	(2,007,076)
Closing Balance at Jun. 30, 2020	$ 0	$ 5,126	$ 85,050,885	$ (73,380,946)	$ 42,149	$ 11,717,214
Closing Balance (in shares) at Jun. 30, 2020	1	5,126,834

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 17 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Interim Statements of Cash Flows - USD ($)	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Operating activities
Net loss for the period	$ (2,007,076)	$ (2,120,644)
Adjustment for items not affecting cash
Depreciation	18,112	23,970
Amortization	23,504	69,314
Interest expense	74,975	13,283
Share based compensation expense	407,315	287,757
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities	(1,483,170)	(1,726,320)
Changes in non-cash working capital items
Accounts receivable	(128,308)	496,181
Prepaid expenses and other receivables	(90,798)	160,305
Due from related parties	(817)	(483)
Inventories	114,472	(176,376)
Accounts payable	(413,219)	(93,835)
Accrued liabilities	406,425	(41,434)
Deferred revenue	(33,782)	58,016
Net cash (used in) operating activities	(1,629,197)	(1,323,946)
Investing activities
Acquisition of equipment	0	(42,802)
Net cash (used in) investing activities	0	(42,802)
Financing activities
Proceeds from convertible loans	1,302,575	950,000
Proceeds from PPP Loan	459,912	0
Proceeds from term loan	0	500,000
Net cash provided by financing activities	1,762,487	1,450,000
Net increase in cash and cash equivalents for the period	133,290	83,252
Cash and cash equivalents, beginning of the period	2,269,747	2,269,747
Cash and cash equivalents, end of the period	$ 2,403,037	$ 530,031

XML 18 R7.htm IDEA: XBRL DOCUMENT

NATURE OF OPERATIONS AND GOING CONCERN	3 Months Ended
NATURE OF OPERATIONS AND GOING CONCERN	Jun. 30, 2020
NATURE OF OPERATIONS AND GOING CONCERN
NATURE OF OPERATIONS AND GOING CONCERN	1. NATURE OF OPERATIONS AND GOING CONCERN The Company and its Operations Bionik Laboratories Corp. (the “Company” or “Bionik”) was incorporated on January 8, 2010 in the State of Colorado as Strategic Dental Management Corp. On July 16, 2013, the Company changed its name to Drywave Technologies Inc. (“Drywave”) and its state of incorporation from Colorado to Delaware. Effective February 13, 2015, the Company changed its name to Bionik Laboratories Corp. and reduced the authorized number of shares of common stock from 200,000,000 to 150,000,000. Concurrently, the Company implemented a 1-for-0.831105 reverse stock split of the common stock, which had previously been approved on September 24, 2014. On October 29, 2018, the Company implemented at 1 for 150 reverse stock-split of the common and exchangeable shares. On February 26, 2015, the Company entered into a Share Exchange Agreement and related transactions whereby it acquired Bionik Laboratories Inc., a Canadian Corporation (“Bionik Canada”) and Bionik Canada issued 333,334 Exchangeable Shares, representing a 3.14 exchange ratio, for 100% of the then outstanding common shares of Bionik Canada (the “Merger”). The Exchangeable Shares are exchangeable at the option of the holder, each into one share of the common stock of the Company. In addition, the Company issued one Special Preferred Voting Share (the “Special Preferred Share”) (Note 10). On April 21, 2016, the Company acquired all of the outstanding shares and, accordingly, all assets and liabilities of Interactive Motion Technologies, Inc. (IMT), a Boston, Massachusetts-based global pioneer and leader in providing effective robotic products for neurorehabilitation, pursuant to an Agreement and Plan of Merger (the “Merger Agreement”) dated March 1, 2016, with IMT, Hermano Igo Krebs, and Bionik Mergerco Inc., a Massachusetts corporation and the Company’s wholly owned subsidiary (Bionik Mergerco). The merger agreement provided for the merger of Bionik Mergerco with and into IMT, with IMT surviving the merger as the Company’s wholly owned subsidiary. In return for acquiring IMT, IMT shareholders received an aggregate of 157,667 shares of the Company’s common stock (Note 4). On November 6, 2017, the Company approved an increase in its authorized shares of common stock to 250,000,000 from 150,000,000, and on June 12, 2018, the Company approved an increase in its authorized shares of common stock to 500,000,000 from 250,000,000. References to the Company refer to the Company and its wholly owned subsidiaries, Bionik Inc., Bionik Acquisition Inc. and Bionik Canada. The Company is a global pioneering robotics company focused on providing rehabilitation solutions to individuals with neurological disorders, specializing in designing, developing and commercializing cost-effective physical rehabilitation technologies, prosthetics, and assisted robotic products. The Company strives to innovate and build devices that can rehabilitate and improve an individual’s health, comfort, accessibility and quality of life through the use of advanced algorithms and sensing technologies that anticipate a user’s every move. These unaudited condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), which contemplates continuation of the Company as a going concern, which assumes the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The Company’s principal offices are located at 483 Bay Street, N105, Toronto, Ontario, Canada M5G 2C9 and its U.S. address is 80 Coolidge Hill Road, Watertown, MA 02472. Going Concern As at June 30, 2020, the Company had a working capital deficit of $931,222 (March 31, 2020 - working capital of $626,923) and an accumulated deficit of $(73,380,946) (March 31, 2020 $(71,373,870)) and the Company incurred a net loss and comprehensive loss of $(2,007,076) for the three month period ended June 30, 2020 (June 30, 2019 – $(2,120,644). There is no certainty that the Company will be successful in generating sufficient cash flow from operations or achieving and maintaining profitable operations in the future to enable it to meet its obligations as they come due and consequently continue as a going concern. The Company will require additional financing to fund its operations and it is currently working on securing this funding through corporate collaborations, public or private equity offerings or debt financings. Sales of additional equity securities by the Company would result in the dilution of the interests of existing stockholders. There can be no assurance that financing will be available when required. In the event that the necessary additional financing is not obtained, the Company would reduce its discretionary overhead costs substantially or otherwise curtail operations. The Company expects to raise additional funds to meet the Company’s anticipated cash requirements for the next 12 months; however, these conditions raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments to reflect the possible future effects on recoverability and reclassification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty. All adjustments, consisting only of normal recurring items, considered necessary for fair presentation have been included in these consolidated financial statements.

XML 19 R8.htm IDEA: XBRL DOCUMENT

BASIS OF PRESENTATION	3 Months Ended
BASIS OF PRESENTATION	Jun. 30, 2020
BASIS OF PRESENTATION
BASIS OF PRESENTATION	2. BASIS OF PRESENTATION During the 2019 fiscal year, holders of the common stock and exchangeable shares of the Company approved, through a majority shareholder vote, an amendment to the Company’s Amended and Restated Certificate of Incorporation authorizing the Board of Directors to effect a reverse stock split of Bionik’s common stock and exchangeable shares at a ratio up to one-to-one hundred and fifty. The preparation of these consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ materially from those estimates. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of June 30, 2020 and through the date of this report filing.

XML 20 R9.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
SIGNIFICANT ACCOUNTING POLICIES	Jun. 30, 2020
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES	3. SIGNIFICANT ACCOUNTING POLICIES Unaudited Condensed Consolidated Interim Financial Statements These unaudited condensed consolidated interim financial statements have been prepared on the same basis as the annual audited financial statements of the Company and should be read in conjunction with those annual audited financial statements filed on Form 10‑K for the year ended March 31, 2020. The interim disclosures generally do not repeat those in the annual statements. In the opinion of management, these unaudited condensed consolidated interim financial statements reflect all adjustments necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods shown. The results of operations for such periods are not necessarily indicative of the results expected for a full year or for any future period. The changes in accounting policies in the Company’s unaudited condensed consolidated interim financial statements from the March 31, 2020 audited financial statements are described below. Newly Adopted and Recently Issued Accounting Pronouncements Newly Adopted In January 2017, the FASB issued ASU 2017-01, “Business Combinations: Clarifying the definition of a Business” which amends the current definition of a business. Under ASU 2017-01, to be considered a business, an acquisition would have to include an input and a substantive process that together significantly contributes to the ability to create outputs. ASU 2017-01 further states that when substantially all of the fair value of gross assets acquired is concentrated in a single asset (or a group of similar assets), the assets acquired would not represent a business. The new guidance also narrows the definition of the term “outputs” to be consistent with how it is described in Topic 606, Revenue from Contracts with Customers. The changes to the definition of a business will likely result in more acquisitions being accounted for as asset acquisitions. ASU 2017-01 is effective for acquisitions commencing on or after December 31, 2019, with early adoption permitted. Adoption of this guidance will be applied prospectively on or after the effective date and the Company does not expect this policy will have a material effect on the consolidated balance sheet or consolidated statement of cash flows. In January 2017, the FASB issued ASU 2017-04, “Intangibles – Goodwill and Other” ASU 2017-04 simplifies the accounting for goodwill impairment by eliminating Step 2 of the current goodwill impairment test, which required a hypothetical purchase price allocation. Goodwill impairment will now be the amount by which the reporting unit’s carrying value exceeds its fair value, limited to the carrying value of the goodwill. ASU 2017-04 is effective for financial statements issued for fiscal years, and interim periods beginning after December 15, 2019. The Company has adopted ASU 2017-04 and it did not have a material effect on the consolidated balance sheet and consolidated statement of operations. In June 2016, the FASB issued ASU 2016-13 Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments, which introduces an expected credit loss methodology for the impairment of financial assets measured at amortized cost basis. The methodology replaces the probable, incurred loss model for those assets. The update if effective for fiscal years beginning after December 15, 2019. The Company has adopted ASU 2016-13 and it did not have a material effect on the consolidated balance sheet and consolidated statement of operations. Recently issued Accounting Standards Update 2020-06—Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity: simplifies accounting for convertible instruments by removing major separation models required under current Generally Accepted Accounting Principles (GAAP). Consequently, more convertible debt instruments will be reported as a single liability instrument and more convertible preferred stock as a single equity instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU also simplifies the diluted earnings per share (EPS) calculation in certain areas. The amendments in this Update are effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is assessing the impact that the adoption of ASU 2020-06 will have on the consolidated balance sheet and consolidated statement of operations. Canada Emergency Wage Subsidy (CEWS) CEWS is recognized as other income in the consolidated statement of operations in the period in which the Company recognizes expenses for which CEWS is intended to compensate. Warranty Reserve and Deferred Warranty Revenue The Company provides a one-year warranty as part of its normal sales offering. When products are sold, the Company provides warranty reserves, which, based on the historical experience of the Company are sufficient to cover warranty claims. Accrued warranty reserves are included in accrued liabilities on the condensed consolidated interim balance sheets and amounted to $81,225 at June 30, 2020 (March 31, 2020 - $162,449). The Company also sells extended warranties for additional periods beyond the standard warranty. Extended warranty revenue is deferred and recognized as revenue over the extended warranty period. The Company recognized $Nil of expenses related to warranty expenses. Additionally, the Company reversed $81,224 of its warranty provision due to low warranty claims and recorded this expense and reversal in cost of goods sold for the three-month period ended June 30, 2020 (June 30, 2019 – $26,911).

XML 21 R10.htm IDEA: XBRL DOCUMENT

TECHNOLOGY AND OTHER ASSETS

3 Months Ended

Jun. 30, 2020

TECHNOLOGY AND OTHER ASSETS

TECHNOLOGY AND OTHER ASSETS

4. TECHNOLOGY AND OTHER ASSETS


		Value	Impairment	Expenses	Value at	Expenses	Value at
	Amortization	acquired		March 31, 2020	March 31, 2020	June 30, 2020	June 30, 2020
Intangible assets acquired	period (years)	$	$	$	$	$	$
Patents and exclusive License Agreement	9.74	1,306,031	307,388	134,090	469,962	20,277	449,685
Trademark	Indefinite	2,505,907	1,605,907	—	900,000	—	900,000
Customer relationships	10	1,431,680	787,245	143,168	79,962	3,227	76,735
Non compete agreement	2	61,366	—	—	—	—	—
Assembled workforce	1	275,720	—	—	—	—	—
		5,580,704	2,700,540	277,258	1,449,924	23,504	1,426,420

The cumulative amortization for the technology and other assets was $1,453,744 at June 30, 2020 (March 31, 2020- $1,430,240).

XML 22 R11.htm IDEA: XBRL DOCUMENT

PREPAID EXPENSES AND OTHER RECEIVABLES

3 Months Ended

Jun. 30, 2020

PREPAID EXPENSES AND OTHER RECEIVABLES

PREPAID EXPENSES AND OTHER RECEIVABLES

5. PREPAID EXPENSES AND OTHER RECEIVABLES


	June 30,	March 31,
	2020	2020
	$	$
Prepaid expenses and other receivables	34,272	78,816
Prepaid inventory	1,499,042	1,450,024
Prepaid insurance	176,928	57,226
Sales taxes receivable (i)	13,111	46,489
	1,723,353	1,632,555

i)Sales tax receivable represents net harmonized sales taxes (HST) input tax credits receivable from the Government of Canada.

XML 23 R12.htm IDEA: XBRL DOCUMENT

INVENTORIES

3 Months Ended

Jun. 30, 2020

INVENTORIES

INVENTORIES

6. INVENTORIES

XML 24 R13.htm IDEA: XBRL DOCUMENT

EQUIPMENT

3 Months Ended

Jun. 30, 2020

EQUIPMENT

EQUIPMENT

7. EQUIPMENT

Equipment consisted of the following as at June 30, 2020 and March 31, 2020:


	June 30, 2020			March 31, 2020
		Accumulated			Accumulated
	Cost	Depreciation	Net	Cost	Depreciation	Net
	$	$	$	$	$	$
Computers and electronics	303,337	269,174	34,163	303,337	264,520	38,817
Furniture and fixtures	36,795	31,240	5,555	36,795	30,953	5,842
Demonstration equipment	135,543	49,395	86,148	135,543	37,662	97,881
Manufacturing equipment	88,742	86,789	1,953	88,742	86,688	2,054
Tools and parts	11,422	7,813	3,609	11,422	7,627	3,795
Assets under capital lease	23,019	18,415	4,604	23,019	17,264	5,755
	598,858	462,826	136,032	598,858	444,714	154,144

Equipment is recorded at cost less accumulated depreciation. Depreciation expense during the three-month period ended June 30, 2020 was $18,112 (June 30, 2019 - $23,970).

XML 25 R14.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE

3 Months Ended

Jun. 30, 2020

NOTES PAYABLE

NOTES PAYABLE

8. NOTES PAYABLE

(a) Convertible Loans Payable

(i)

(ii)

In the event the Company raises capital through the sale of Common Stock for cash during the period ending on the three year anniversary of the issuance date of the convertible notes, and the price per share thereof (the “Offering Price”) minus 20% is less than the original Conversion Price, then in such event the Company shall issue to all convertible loan holder at, at no further cost, additional shares of common stock equal to the number of conversion shares the holders would have received upon conversion if the Conversion Price equaled to a 20% discount to the Offering Price, less the number of shares of conversion shares actually issued on or as of the Maturity Date. Since the Company has early adopted ASU 2017-11, the anti-dilution protection clause does not contribute to the conversion feature to be a derivative liability.

The interest accrued on these convertible loans for the period ended June 30, 2020 was $15,588 (March 31, 2020- $4,317).

(b) Short term loan

On May 1, 2020, the Company signed a Promissory Note for $459,912 pursuant to the federal Paycheck Protection Program under the Coronavirus Aid, Relief and Economic Security Act, which is administered by the U.S. Small Business Administration. The loan is unsecured, bears interest of 1% per annum and a deferment period of 6 months. The loan is to be used primarily for payroll related costs, lease and utility payments. The Company intends to apply for forgiveness for all or a portion of the loans in accordance with applicable law. If the loan is not forgiven, the Company will be obligated to repay the loan during the period of 2 years.

XML 26 R15.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS AND BALANCES	3 Months Ended
RELATED PARTY TRANSACTIONS AND BALANCES	Jun. 30, 2020
RELATED PARTY TRANSACTIONS AND BALANCES
RELATED PARTY TRANSACTIONS AND BALANCES	9. RELATED PARTY TRANSACTIONS AND BALANCES (a) Due from related parties At June 30, 2020 there was an outstanding loan to the Chief Technology Officer (“CTO”) of the Company of 18,657(March 31, 2020 – $17,840).The loan has an Interest rate of 2% based on the Canada Revenue Agency’s prescribed rate for such advances and is denominated in Canadian dollars. During the period ended June 30, 2020, the Company accrued interest receivable in the amount of $90 (March 31, 2020 – $472); the remaining fluctuation in the balance from the prior year is due to changes in foreign exchange. (b) Accounts payable and accrued liabilities As at June 30, 2020, $193,285 (March 31, 2020 – $30,866 ) was owing to the CEO of the Company; $57,246 (March 31, 2020 – $9,464) was owing to the Chief Technology Officer; $70,963 (March 31, 2020 – $1,827 )was owing to the Chief Financial Officer (“CFO”), $32,472 (March 31, 2020 - $Nil) was owing to the Chief Commercial Officer (“CCO”), all related to bonuses and business expenses.

XML 27 R16.htm IDEA: XBRL DOCUMENT

SHARE CAPITAL

3 Months Ended

Jun. 30, 2020

SHARE CAPITAL

SHARE CAPITAL

10. SHARE CAPITAL


	June 30, 2020		March 31, 2020
	Number of		Number of
	shares	$	shares	$
Exchangeable Shares
Balance beginning of period	117,683	118	196,799	197
Converted into common shares (a)	—	—	(79,116)	(79)
Balance at end of period	117,683	118	117,683	118
Common Shares
Balance at beginning of the period	5,009,151	5,008	3,661,838	3,661
Shares issued to exchangeable shareholders (a)	—	—	79,116	79
Shares issued on conversion of loans	—	—	1,268,191	1,268
Share consolidation rounding adjustment	—	—	6	—
Balance at end of the period	5,009,151	5,008	5,009,151	5,008
TOTAL SHARES	5,126,834	5,126	5,126,834	5,126

(a)During the quarter ended June 30, 2020, Nil exchangeable shares were exchanged for common shares on a 1 for 1 basis in accordance with their terms. (March 31, 2020 – 79,116 shares)

Special Voting Preferred Share

XML 28 R17.htm IDEA: XBRL DOCUMENT

STOCK OPTIONS

3 Months Ended

Jun. 30, 2020

STOCK OPTIONS

STOCK OPTIONS

11. STOCK OPTIONS

During the quarter ended June 30, 2020, the Company recorded $407,315 in share-based compensation related to the vesting of stock options (June 30, 2019 – $287,757).

The following is a summary of stock options outstanding and exercisable as of June 30, 2020:


Exercise Price ($)	Number of Options	Expiry Date	Exercisable Options
34.500	630	20-Jun-21	630
34.500	13,212	01-Jul-21	13,212
34.500	944	17-Feb-22	944
183.000	2,667	24-Nov-22	2,667
150.000	11,400	14-Dec-22	11,400
142.500	359	28-Mar-23	359
157.500	1,387	28-Mar-23	1,387
105.000	2,667	06-Feb-24	2,667
102.000	1,667	13-Feb-24	1,667
142.500	106	03-Mar-24	106
157.500	408	03-Mar-24	408
142.500	43	14-Mar-24	43
157.500	164	14-Mar-24	164
142.500	327	30-Sep-24	327
157.500	1,264	30-Sep-24	1,264
24.150	81,436	01-Sep-27	40,722
23.250	13,064	24-Jan-25	9,132
9.735	40,000	19-Apr-28	40,000
3.16	168,283	31-May-26	168,283
3.595	473,151	26-July-26	56,417
3.20	5,000	03-Sep-26	—
	818,179		351,798

XML 29 R18.htm IDEA: XBRL DOCUMENT

WARRANTS

3 Months Ended

Jun. 30, 2020

WARRANTS

WARRANTS

12. WARRANTS

The following is a continuity schedule of the Company’s common share purchase warrants:


		Weighted
		Average
	Number of	Exercise Price
	Warrants	($)
Outstanding and exercisable, March 31, 2019	288,517	40.27
Expired	(163,483)	(38.91)
Outstanding and exercisable, March 31, 2020	125,034	20.07
Expired	(2,667)	(37.50)
Outstanding and exercisable June 30, 2020	122,367	19.69

During the quarter ended June 30, 2020, 2,667 warrants expired in accordance with their terms.

Common share purchase warrants

The following is a summary of common share purchase warrants outstanding as of June 30, 2020.


Exercise	Number of
Price ($)	Warrants	Expiry Date
90.00	15,658	March 31, 2023
9.375	64,025	August 14, 2022
9.375	42,684	March 31, 2022
	122,367

The weighted-average remaining contractual term of the outstanding warrants was 2.07.

XML 30 R19.htm IDEA: XBRL DOCUMENT

COMMITMENTS AND CONTINGENCIES	3 Months Ended
COMMITMENTS AND CONTINGENCIES	Jun. 30, 2020
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	13. COMMITMENTS AND CONTINGENCIES Contingencies From time to time, the Company may be involved in a variety of claims, suits, investigations and proceedings arising in the ordinary course of our business, collections claims, breach of contract claims, labor and employment claims, tax and other matters. Although claims, suits, investigations and proceedings are inherently uncertain and their results cannot be predicted with certainty, the Company believes that the resolution of current pending matters will not have a material adverse effect on its business, financial position, results of operations or cash flow. Regardless of the outcome, litigation can have an adverse impact on the Company because of legal costs, diversion of management resources and other factors. Commitments (a)On February 25, 2015, 1,753 common shares were issued to two former lenders connected with a $241,185 loan received and repaid during fiscal 2013. The common shares were valued at $210,323 based on the value of the concurrent private placement and recorded in stock-based compensation on the consolidated statement of operations and comprehensive loss. As part of the consideration for the initial loan, the Company's then-CTO and COO had transferred 2,098 common shares to the lenders. For contributing the common shares to the lenders, the Company intends to reimburse the former CTO and COO 2,134 common shares. As at June 30, 2020 these shares have not yet been issued. (b)On May 17, 2017, the Company entered into a Co-operative Joint Venture Contract (the “JV Contract”) with Ginger Capital Investment Holding, Ltd. (the “JV Partner”) to form China Bionik Medical Rehabilitation Technology Ltd. (“China JV”), pursuant to which, among other things, the Company was to have a 25% interest and the JV Partner a 75% interest. The Company applied the equity method of accounting to the joint venture. The Company gave notice on May 18, 2020 to the JV Partner of the termination of the China JV as well as terminating the Licensing and Distribution agreements with the China JV. As a result of the termination of the China JV and related commercial agreements, the Company has been communicating with its counterparts regarding such termination. (c)In connection with the acquisition of IMT, the Company acquired a license agreement dated June 8, 2009, with a former director as a co-licenser, pursuant to which the Company pays the director and the co-licenser an aggregate royalty of 1% of sales based on patent #8,613,691. No sales have been made, as the technology under this patent has not been commercialized.

XML 31 R20.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS	3 Months Ended
SUBSEQUENT EVENTS	Jun. 30, 2020
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	14. SUBSEQUENT EVENTS (a)Subsequent to June 30, 2020, the Company received an additional $200,000 from lenders under the terms of the convertible loans described in Note 8 (a).

XML 32 R21.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
SIGNIFICANT ACCOUNTING POLICIES (Policies)	Jun. 30, 2020
SIGNIFICANT ACCOUNTING POLICIES
Unaudited Condensed Consolidated Interim Financial Statements	Unaudited Condensed Consolidated Interim Financial Statements These unaudited condensed consolidated interim financial statements have been prepared on the same basis as the annual audited financial statements of the Company and should be read in conjunction with those annual audited financial statements filed on Form 10‑K for the year ended March 31, 2020. The interim disclosures generally do not repeat those in the annual statements. In the opinion of management, these unaudited condensed consolidated interim financial statements reflect all adjustments necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods shown. The results of operations for such periods are not necessarily indicative of the results expected for a full year or for any future period. The changes in accounting policies in the Company’s unaudited condensed consolidated interim financial statements from the March 31, 2020 audited financial statements are described below.
Newly Adopted and Recently Issued Accounting Pronouncements	Newly Adopted and Recently Issued Accounting Pronouncements Newly Adopted In January 2017, the FASB issued ASU 2017-01, “Business Combinations: Clarifying the definition of a Business” which amends the current definition of a business. Under ASU 2017-01, to be considered a business, an acquisition would have to include an input and a substantive process that together significantly contributes to the ability to create outputs. ASU 2017-01 further states that when substantially all of the fair value of gross assets acquired is concentrated in a single asset (or a group of similar assets), the assets acquired would not represent a business. The new guidance also narrows the definition of the term “outputs” to be consistent with how it is described in Topic 606, Revenue from Contracts with Customers. The changes to the definition of a business will likely result in more acquisitions being accounted for as asset acquisitions. ASU 2017-01 is effective for acquisitions commencing on or after December 31, 2019, with early adoption permitted. Adoption of this guidance will be applied prospectively on or after the effective date and the Company does not expect this policy will have a material effect on the consolidated balance sheet or consolidated statement of cash flows. In January 2017, the FASB issued ASU 2017-04, “Intangibles – Goodwill and Other” ASU 2017-04 simplifies the accounting for goodwill impairment by eliminating Step 2 of the current goodwill impairment test, which required a hypothetical purchase price allocation. Goodwill impairment will now be the amount by which the reporting unit’s carrying value exceeds its fair value, limited to the carrying value of the goodwill. ASU 2017-04 is effective for financial statements issued for fiscal years, and interim periods beginning after December 15, 2019. The Company has adopted ASU 2017-04 and it did not have a material effect on the consolidated balance sheet and consolidated statement of operations. In June 2016, the FASB issued ASU 2016-13 Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments, which introduces an expected credit loss methodology for the impairment of financial assets measured at amortized cost basis. The methodology replaces the probable, incurred loss model for those assets. The update if effective for fiscal years beginning after December 15, 2019. The Company has adopted ASU 2016-13 and it did not have a material effect on the consolidated balance sheet and consolidated statement of operations.
Recently Issued	Recently issued Accounting Standards Update 2020-06—Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity: simplifies accounting for convertible instruments by removing major separation models required under current Generally Accepted Accounting Principles (GAAP). Consequently, more convertible debt instruments will be reported as a single liability instrument and more convertible preferred stock as a single equity instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU also simplifies the diluted earnings per share (EPS) calculation in certain areas. The amendments in this Update are effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is assessing the impact that the adoption of ASU 2020-06 will have on the consolidated balance sheet and consolidated statement of operations.
Canada Emergency Wage Subsidy (CEWS)	Canada Emergency Wage Subsidy (CEWS) CEWS is recognized as other income in the consolidated statement of operations in the period in which the Company recognizes expenses for which CEWS is intended to compensate.
Warranty Reserve and Deferred Warranty Revenue	Warranty Reserve and Deferred Warranty Revenue The Company provides a one-year warranty as part of its normal sales offering. When products are sold, the Company provides warranty reserves, which, based on the historical experience of the Company are sufficient to cover warranty claims. Accrued warranty reserves are included in accrued liabilities on the condensed consolidated interim balance sheets and amounted to $81,225 at June 30, 2020 (March 31, 2020 - $162,449). The Company also sells extended warranties for additional periods beyond the standard warranty. Extended warranty revenue is deferred and recognized as revenue over the extended warranty period. The Company recognized $Nil of expenses related to warranty expenses. Additionally, the Company reversed $81,224 of its warranty provision due to low warranty claims and recorded this expense and reversal in cost of goods sold for the three-month period ended June 30, 2020 (June 30, 2019 – $26,911).

XML 33 R22.htm IDEA: XBRL DOCUMENT

TECHNOLOGY AND OTHER ASSETS (Tables)

3 Months Ended

Jun. 30, 2020

TECHNOLOGY AND OTHER ASSETS

Schedule of intangible assets acquired in the IMT acquisition


		Value	Impairment	Expenses	Value at	Expenses	Value at
	Amortization	acquired		March 31, 2020	March 31, 2020	June 30, 2020	June 30, 2020
Intangible assets acquired	period (years)	$	$	$	$	$	$
Patents and exclusive License Agreement	9.74	1,306,031	307,388	134,090	469,962	20,277	449,685
Trademark	Indefinite	2,505,907	1,605,907	—	900,000	—	900,000
Customer relationships	10	1,431,680	787,245	143,168	79,962	3,227	76,735
Non compete agreement	2	61,366	—	—	—	—	—
Assembled workforce	1	275,720	—	—	—	—	—
		5,580,704	2,700,540	277,258	1,449,924	23,504	1,426,420

XML 34 R23.htm IDEA: XBRL DOCUMENT

PREPAID EXPENSES AND OTHER RECEIVABLES (Tables)

3 Months Ended

Jun. 30, 2020

PREPAID EXPENSES AND OTHER RECEIVABLES

Schedule of prepaid expenses and other receivables


	June 30,	March 31,
	2020	2020
	$	$
Prepaid expenses and other receivables	34,272	78,816
Prepaid inventory	1,499,042	1,450,024
Prepaid insurance	176,928	57,226
Sales taxes receivable (i)	13,111	46,489
	1,723,353	1,632,555

i)Sales tax receivable represents net harmonized sales taxes (HST) input tax credits receivable from the Government of Canada.

XML 35 R24.htm IDEA: XBRL DOCUMENT

INVENTORIES (Tables)

3 Months Ended

Jun. 30, 2020

INVENTORIES

Schedule of inventory

XML 36 R25.htm IDEA: XBRL DOCUMENT

EQUIPMENT (Tables)

3 Months Ended

Jun. 30, 2020

EQUIPMENT

Schedule of components of equipment

Equipment consisted of the following as at June 30, 2020 and March 31, 2020:


	June 30, 2020			March 31, 2020
		Accumulated			Accumulated
	Cost	Depreciation	Net	Cost	Depreciation	Net
	$	$	$	$	$	$
Computers and electronics	303,337	269,174	34,163	303,337	264,520	38,817
Furniture and fixtures	36,795	31,240	5,555	36,795	30,953	5,842
Demonstration equipment	135,543	49,395	86,148	135,543	37,662	97,881
Manufacturing equipment	88,742	86,789	1,953	88,742	86,688	2,054
Tools and parts	11,422	7,813	3,609	11,422	7,627	3,795
Assets under capital lease	23,019	18,415	4,604	23,019	17,264	5,755
	598,858	462,826	136,032	598,858	444,714	154,144

XML 37 R26.htm IDEA: XBRL DOCUMENT

SHARE CAPITAL (Tables)

3 Months Ended

Jun. 30, 2020

SHARE CAPITAL

Schedule of share capital


	June 30, 2020		March 31, 2020
	Number of		Number of
	shares	$	shares	$
Exchangeable Shares
Balance beginning of period	117,683	118	196,799	197
Converted into common shares (a)	—	—	(79,116)	(79)
Balance at end of period	117,683	118	117,683	118
Common Shares
Balance at beginning of the period	5,009,151	5,008	3,661,838	3,661
Shares issued to exchangeable shareholders (a)	—	—	79,116	79
Shares issued on conversion of loans	—	—	1,268,191	1,268
Share consolidation rounding adjustment	—	—	6	—
Balance at end of the period	5,009,151	5,008	5,009,151	5,008
TOTAL SHARES	5,126,834	5,126	5,126,834	5,126

(a)During the quarter ended June 30, 2020, Nil exchangeable shares were exchanged for common shares on a 1 for 1 basis in accordance with their terms. (March 31, 2020 – 79,116 shares)

XML 38 R27.htm IDEA: XBRL DOCUMENT

STOCK OPTIONS (Tables)

3 Months Ended

Jun. 30, 2020

STOCK OPTIONS

Schedule of stock options outstanding and exercisable

The following is a summary of stock options outstanding and exercisable as of June 30, 2020:


Exercise Price ($)	Number of Options	Expiry Date	Exercisable Options
34.500	630	20-Jun-21	630
34.500	13,212	01-Jul-21	13,212
34.500	944	17-Feb-22	944
183.000	2,667	24-Nov-22	2,667
150.000	11,400	14-Dec-22	11,400
142.500	359	28-Mar-23	359
157.500	1,387	28-Mar-23	1,387
105.000	2,667	06-Feb-24	2,667
102.000	1,667	13-Feb-24	1,667
142.500	106	03-Mar-24	106
157.500	408	03-Mar-24	408
142.500	43	14-Mar-24	43
157.500	164	14-Mar-24	164
142.500	327	30-Sep-24	327
157.500	1,264	30-Sep-24	1,264
24.150	81,436	01-Sep-27	40,722
23.250	13,064	24-Jan-25	9,132
9.735	40,000	19-Apr-28	40,000
3.16	168,283	31-May-26	168,283
3.595	473,151	26-July-26	56,417
3.20	5,000	03-Sep-26	—
	818,179		351,798

XML 39 R28.htm IDEA: XBRL DOCUMENT

WARRANTS (Tables)

3 Months Ended

Jun. 30, 2020

WARRANTS

Schedule of continuity schedule

The following is a continuity schedule of the Company’s common share purchase warrants:


		Weighted
		Average
	Number of	Exercise Price
	Warrants	($)
Outstanding and exercisable, March 31, 2019	288,517	40.27
Expired	(163,483)	(38.91)
Outstanding and exercisable, March 31, 2020	125,034	20.07
Expired	(2,667)	(37.50)
Outstanding and exercisable June 30, 2020	122,367	19.69

Schedule of common share purchase warrants outstanding

The following is a summary of common share purchase warrants outstanding as of June 30, 2020.


Exercise	Number of
Price ($)	Warrants	Expiry Date
90.00	15,658	March 31, 2023
9.375	64,025	August 14, 2022
9.375	42,684	March 31, 2022
	122,367

XML 40 R29.htm IDEA: XBRL DOCUMENT

NATURE OF OPERATIONS AND GOING CONCERN (Details)						3 Months Ended		12 Months Ended
NATURE OF OPERATIONS AND GOING CONCERN (Details)	Oct. 29, 2018	Apr. 21, 2016 shares	Feb. 26, 2015 shares	Feb. 25, 2015 shares	Feb. 13, 2015	Jun. 30, 2020 USD ($) shares	Jun. 30, 2019 USD ($)	Mar. 31, 2020 USD ($) shares	Jun. 12, 2018 shares	Nov. 06, 2017 shares	Mar. 31, 2017 shares	Dec. 31, 2014 shares
Common Stock, Shares Authorized						500,000,000		500,000,000	500,000,000	250,000,000	150,000,000	200,000,000
Reverse stock split ratio	0.0067				0.831105			0.0067
Stock Issued During Period, Shares, New Issues				1,753
Working Capital Surplus \| $						$ 931,222		$ 626,923
Retained Earnings (Accumulated Deficit) \| $						(73,380,946)		$ (71,373,870)
Comprehensive Income (Loss), Net of Tax \| $						$ (2,007,076)	$ (2,120,644)
Interactive Motion Technologies, Inc. [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares		157,667
Share Exchange Agreement [Member]
Stock Issued During Period, Shares, New Issues			333,334
Exchange ratio of exchangeable shares to common shares outstanding			3.14
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage			100.00%

XML 41 R30.htm IDEA: XBRL DOCUMENT

BASIS OF PRESENTATION (Details)			12 Months Ended
BASIS OF PRESENTATION (Details)	Oct. 29, 2018	Feb. 13, 2015	Mar. 31, 2020
BASIS OF PRESENTATION
Stockholders' Equity Note, Stock Split, Conversion Ratio	0.0067	0.831105	0.0067

XML 42 R31.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended
SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	Jun. 30, 2020	Jun. 30, 2019	Mar. 31, 2020
SIGNIFICANT ACCOUNTING POLICIES
Standard and Extended Product Warranty Accrual	$ 81,225		$ 162,449
Product Warranty Expense	0	$ 26,911
Reversal of warranty provision	$ 81,224

XML 43 R32.htm IDEA: XBRL DOCUMENT

TECHNOLOGY AND OTHER ASSETS - Intangible assets acquired (Details) - USD ($)	3 Months Ended		12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Mar. 31, 2020
Noncash or Part Noncash Acquisition, Intangible Assets Acquired	$ 5,580,704
Impairment of Intangible Assets (Excluding Goodwill)	2,700,540
Amortization of Intangible Assets	23,504	$ 69,314	$ 277,258
Intangible Assets, Net (Excluding Goodwill)	$ 1,426,420		1,449,924
Patents and Exclusive License Agreement [Member]
Finite-Lived Intangible Asset, Useful Life	9 years 8 months 27 days
Noncash or Part Noncash Acquisition, Intangible Assets Acquired	$ 1,306,031
Impairment of Intangible Assets (Excluding Goodwill)	307,388
Amortization of Intangible Assets	20,277		134,090
Intangible Assets, Net (Excluding Goodwill)	$ 449,685		469,962
Trademark [Member]
Finite Lived Intangible Asset Useful Life Description	Indefinite
Noncash or Part Noncash Acquisition, Intangible Assets Acquired	$ 2,505,907
Impairment of Intangible Assets (Excluding Goodwill)	1,605,907
Amortization of Intangible Assets	0		0
Intangible Assets, Net (Excluding Goodwill)	$ 900,000		900,000
Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life	10 years
Noncash or Part Noncash Acquisition, Intangible Assets Acquired	$ 1,431,680
Impairment of Intangible Assets (Excluding Goodwill)	787,245
Amortization of Intangible Assets	3,227		143,168
Intangible Assets, Net (Excluding Goodwill)	$ 76,735		79,962
Non compete Agreement [Member]
Finite-Lived Intangible Asset, Useful Life	2 years
Noncash or Part Noncash Acquisition, Intangible Assets Acquired	$ 61,366
Amortization of Intangible Assets	0		0
Intangible Assets, Net (Excluding Goodwill)	$ 0		0
Assembled Workforce [Member]
Finite-Lived Intangible Asset, Useful Life	1 year
Noncash or Part Noncash Acquisition, Intangible Assets Acquired	$ 275,720
Amortization of Intangible Assets	0		0
Intangible Assets, Net (Excluding Goodwill)	$ 0		$ 0

XML 44 R33.htm IDEA: XBRL DOCUMENT

TECHNOLOGY AND OTHER ASSETS - Additional Information (Details) - USD ($)	Jun. 30, 2020	Mar. 31, 2020
TECHNOLOGY AND OTHER ASSETS
Technology and other assets cumulative amortization	$ 1,453,744	$ 1,430,240

XML 45 R34.htm IDEA: XBRL DOCUMENT

PREPAID EXPENSES AND OTHER RECEIVABLES (Details) - USD ($)	Jun. 30, 2020	Mar. 31, 2020
PREPAID EXPENSES AND OTHER RECEIVABLES
Prepaid expenses and other receivables	$ 34,272	$ 78,816
Prepaid inventory	1,499,042	1,450,024
Prepaid insurance	176,928	57,226
Sales taxes receivable (i)	13,111	46,489
Total prepaid expenses and other receivables	$ 1,723,353	$ 1,632,555

XML 46 R35.htm IDEA: XBRL DOCUMENT

INVENTORIES- Schedule of Inventories (Details) - USD ($)	Jun. 30, 2020	Mar. 31, 2020
INVENTORIES
Finished Goods	$ 944,990	$ 1,059,462

XML 47 R36.htm IDEA: XBRL DOCUMENT

INVENTORIES - Additional Information (Details) - USD ($)	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cost of Sales	$ 62,555	$ 336,085
Warranty adjustment	0	26,911
Inventory Cost [Member]
Cost of Sales	143,810	$ 299,795
Warranty adjustment	$ 81,224

XML 48 R37.htm IDEA: XBRL DOCUMENT

EQUIPMENT - Schedule of net equipment (Details) - USD ($)	Jun. 30, 2020	Mar. 31, 2020
Equipment [Line Items]
Equipment, Cost	$ 598,858	$ 598,858
Accumulated Depreciation	462,826	444,714
Equipment, Net	136,032	154,144
Computer and electronics [Member]
Equipment [Line Items]
Equipment, Cost	303,337	303,337
Accumulated Depreciation	269,174	264,520
Equipment, Net	34,163	38,817
Furniture and fixtures [Member]
Equipment [Line Items]
Equipment, Cost	36,795	36,795
Accumulated Depreciation	31,240	30,953
Equipment, Net	5,555	5,842
Demonstration equipment [Member]
Equipment [Line Items]
Equipment, Cost	135,543	135,543
Accumulated Depreciation	49,395	37,662
Equipment, Net	86,148	97,881
Manufacturing Equipment [Member]
Equipment [Line Items]
Equipment, Cost	88,742	88,742
Accumulated Depreciation	86,789	86,688
Equipment, Net	1,953	2,054
Tools and parts [Member]
Equipment [Line Items]
Equipment, Cost	11,422	11,422
Accumulated Depreciation	7,813	7,627
Equipment, Net	3,609	3,795
Assets under capital lease [Member]
Equipment [Line Items]
Equipment, Cost	23,019	23,019
Accumulated Depreciation	18,415	17,264
Equipment, Net	$ 4,604	$ 5,755

XML 49 R38.htm IDEA: XBRL DOCUMENT

EQUIPMENT - Additional Information (Details) - USD ($)	3 Months Ended
EQUIPMENT - Additional Information (Details) - USD ($)	Jun. 30, 2020	Jun. 30, 2019
EQUIPMENT
Depreciation	$ 18,112	$ 23,970

XML 50 R39.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE (Details) - USD ($)	3 Months Ended		12 Months Ended
NOTES PAYABLE (Details) - USD ($)	Jun. 30, 2020	Jun. 30, 2019	Mar. 31, 2020	Jan. 01, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Proceeds from convertible loans	$ 1,302,575	$ 950,000
Convertible Loans Payable [Member]
Debt Instrument [Line Items]
Proceeds from convertible loans	1,302,575
Convertible loans received	70,000
Maximum Convertible note offering	$ 7,000,000		$ 3,000,000
Debt Instrument, Interest Rate, Stated Percentage	1.00%
Discount Percentage On Offer Price	20.00%
Interest	$ 15,588		$ 4,317
Convertible Loans Payable with Conversion Price One [Member]
Debt Instrument [Line Items]
Debt Instrument, Convertible, Conversion Price					$ 8.55
Convertible Loans Payable with Conversion Price Two [Member]
Debt Instrument [Line Items]
Debt Instrument, Convertible, Conversion Price				$ 9.50

XML 51 R40.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE - Short term loan (Details) - USD ($)			3 Months Ended
NOTES PAYABLE - Short term loan (Details) - USD ($)	May 01, 2020	Mar. 23, 2020	Jun. 30, 2020	Jun. 30, 2019	Mar. 31, 2020
Debt Instrument [Line Items]
Proceeds from short term loan		$ 2,000,000	$ 0	$ 500,000
Consummation of minimum of equity or debt financing			5,000,000
Interest accrued on loan			$ 64,516		$ 4,516
Promissory Note [Member]
Debt Instrument [Line Items]
Interest rate per month	1.00%	1.00%
Promissory Note signed	$ 459,912
Loan unsecured deferment period	6 months
Repayment of long term loan period	2 years

XML 52 R41.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS AND BALANCES (Details) - USD ($)	3 Months Ended	12 Months Ended
	Jun. 30, 2020	Mar. 31, 2020
RELATED PARTY TRANSACTIONS AND BALANCES
Accrued interest receivable	$ 90	$ 472
Chief Executive Officer [Member]
RELATED PARTY TRANSACTIONS AND BALANCES
Accounts Payable, Related Parties	193,285	30,866
Chief Technology Officer [Member]
RELATED PARTY TRANSACTIONS AND BALANCES
Due from Related Parties	$ 18,657	$ 17,840
Interest Rate On Loan	2.00%	2.00%
Accounts Payable, Related Parties	$ 57,246	$ 9,464
Chief Financial Officer [Member]
RELATED PARTY TRANSACTIONS AND BALANCES
Accounts Payable, Related Parties	70,963	1,827
Chief Commercial Officer [Member]
RELATED PARTY TRANSACTIONS AND BALANCES
Accounts Payable, Related Parties	$ 32,472	$ 0

XML 53 R42.htm IDEA: XBRL DOCUMENT

SHARE CAPITAL - Common shares issued (Details) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Mar. 31, 2020
Opening Balance	$ 13,316,975	$ 25,575,046	$ 27,407,933
Shares issued to exchangeable shareholders (a)		9,143,927
Closing Balance	$ 11,717,214	$ 13,316,975	$ 13,316,975
Exchangeable Shares [Member]
Opening Balance (in shares)	117,683		196,799
Opening Balance	$ 118		$ 197
Converted into common shares (in shares)	0		(79,116)
Converted into common shares (a)	$ 0		$ (79)
Closing Balance (in shares)	117,683	117,683	117,683
Closing Balance	$ 118	$ 118	$ 118
Common Shares [Member]
Opening Balance (in shares)	5,009,151		3,661,838
Opening Balance	$ 5,008		$ 3,661
Shares issued to exchangeable shareholders (in shares)	0		79,116
Shares issued to exchangeable shareholders (a)	$ 0		$ 79
Shares issued on conversion of loans (in shares)	0		1,268,191
Shares issued on conversion of loans	$ 0		$ 1,268
Share consolidation rounding adjustment (in shares)	0		6
Share consolidation rounding adjustment (f)	$ 0		$ 0
Closing Balance (in shares)	5,009,151	5,009,151	5,009,151
Closing Balance	$ 5,008	$ 5,008	$ 5,008
Common Shares And Exchangeable Shares [Member]
Opening Balance (in shares)	5,126,834
Opening Balance	$ 5,126
Closing Balance (in shares)	5,126,834	5,126,834	5,126,834
Closing Balance	$ 5,126	$ 5,126	$ 5,126

XML 54 R43.htm IDEA: XBRL DOCUMENT

SHARE CAPITAL - Additional Information (Details)	12 Months Ended
SHARE CAPITAL - Additional Information (Details)	Mar. 31, 2020 shares
SHARE CAPITAL
Exchangeable Shares exchanged for common shares	79,116

XML 55 R44.htm IDEA: XBRL DOCUMENT

STOCK OPTIONS - Summary of stock options outstanding and exercisable (Details)	3 Months Ended
	Jun. 30, 2020 $ / shares shares
STOCK OPTIONS
Number of Options	818,179
Exercisable Options	351,798
Stock Option One [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 34.500
Number of Options	630
Expiry Date	Jun. 20, 2021
Exercisable Options	630
Stock Option Two [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 34.500
Number of Options	13,212
Expiry Date	Jul. 01, 2021
Exercisable Options	13,212
Stock Option Three [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 34.500
Number of Options	944
Expiry Date	Feb. 17, 2022
Exercisable Options	944
Stock Option Four [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 183.000
Number of Options	2,667
Expiry Date	Nov. 24, 2022
Exercisable Options	2,667
Stock Option Five [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 150.000
Number of Options	11,400
Expiry Date	Dec. 14, 2022
Exercisable Options	11,400
Stock Option Six [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 142.500
Number of Options	359
Expiry Date	Mar. 28, 2023
Exercisable Options	359
Stock Option Seven [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 157.500
Number of Options	1,387
Expiry Date	Mar. 28, 2023
Exercisable Options	1,387
Stock Option Eight [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 105.000
Number of Options	2,667
Expiry Date	Feb. 06, 2024
Exercisable Options	2,667
Stock Option Nine [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 102.000
Number of Options	1,667
Expiry Date	Feb. 13, 2024
Exercisable Options	1,667
Stock Option Ten [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 142.500
Number of Options	106
Expiry Date	Mar. 03, 2024
Exercisable Options	106
Stock Option Eleven [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 157.500
Number of Options	408
Expiry Date	Mar. 03, 2024
Exercisable Options	408
Stock Option Twelve [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 142.500
Number of Options	43
Expiry Date	Mar. 14, 2024
Exercisable Options	43
Stock Option Thirteen [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 157.500
Number of Options	164
Expiry Date	Mar. 14, 2024
Exercisable Options	164
Stock Option Fourteen [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 142.500
Number of Options	327
Expiry Date	Sep. 30, 2024
Exercisable Options	327
Stock Option Fifteen [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 157.500
Number of Options	1,264
Expiry Date	Sep. 30, 2024
Exercisable Options	1,264
Stock Option Sixteen [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 24.150
Number of Options	81,436
Expiry Date	Sep. 01, 2027
Exercisable Options	40,722
Stock Option Seventeen [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 23.250
Number of Options	13,064
Expiry Date	Jan. 24, 2025
Exercisable Options	9,132
Stock Option Eighteen [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 9.735
Number of Options	40,000
Expiry Date	Apr. 19, 2028
Exercisable Options	40,000
Stock Option Nineteen [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 3.16
Number of Options	168,283
Expiry Date	May 31, 2026
Exercisable Options	168,283
Stock Option Twenty [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 3.595
Number of Options	473,151
Expiry Date	Jul. 26, 2026
Exercisable Options	56,417
Stock Option Twenty One [Member]
STOCK OPTIONS
Exercise Price \| $ / shares	$ 3.20
Number of Options	5,000
Expiry Date	Sep. 03, 2026
Exercisable Options	0

XML 56 R45.htm IDEA: XBRL DOCUMENT

STOCK OPTIONS - Additional Information (Details) - USD ($)						3 Months Ended		12 Months Ended
	Sep. 03, 2019	Jul. 26, 2019	May 31, 2019	Jan. 24, 2018	Sep. 01, 2017	Jun. 30, 2020	Jun. 30, 2019	Mar. 31, 2020	Mar. 31, 2019
STOCK OPTIONS
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number						818,179
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term						6 years 7 days		6 years 3 months 11 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term						5 years 10 months 2 days		6 years 1 month 13 days
Employee Stock Option [Member]
STOCK OPTIONS
Allocated Share-based Compensation Expense						$ 407,315	$ 287,757
Employees [Member]
STOCK OPTIONS
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period						266			7,334
Director and Employees [Member]
STOCK OPTIONS
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price			$ 3.16
Allocated Share-based Compensation Expense						$ 50,755
Grant fair value			$ 453,585
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period			7 years
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period			169,882
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term			7 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate			114.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate			1.59%
Director and Employees [Member] \| Minimum [Member]
STOCK OPTIONS
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			6 months
Director and Employees [Member] \| Maximum [Member]
STOCK OPTIONS
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			1 year 6 months
Executive Employee And Consultant [Member]
STOCK OPTIONS
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					81,436
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price					$ 24.15
Allocated Share-based Compensation Expense						$ 57,259	57,259
Grant fair value					$ 1,832,304
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage					50.00%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares					27,148
Executive Employee And Consultant [Member] \| Share-based Payment Arrangement, Tranche Two [Member]
STOCK OPTIONS
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage					50.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period					5 years
Employees and consultants [Member] \| Employee Stock Option [Member]
STOCK OPTIONS
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		484,612
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price		$ 3.595
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period						1,286		11,461
Allocated Share-based Compensation Expense						$ 269,579
Grant fair value		$ 1,525,525
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term		7 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate		114.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate		1.59%
Employee [Member]
STOCK OPTIONS
Allocated Share-based Compensation Expense						28,554	$ 28,554
Grant fair value				$ 491,036
Employee [Member] \| Employee Stock Option [Member]
STOCK OPTIONS
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	5,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$ 3.20
Allocated Share-based Compensation Expense						$ 1,168
Grant fair value	$ 14,010
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	7 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	114.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	1.59%
Employees vest equally on January 24, 2019 [Member]
STOCK OPTIONS
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross				24,267
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price				$ 23.25
Employees vest equally on January 24 2020 [Member]
STOCK OPTIONS
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price				23.25
Employees vest equally on January 24 2021 [Member]
STOCK OPTIONS
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price				$ 23.25

XML 57 R46.htm IDEA: XBRL DOCUMENT

WARRANTS - Summary of continuity schedule (Details) - $ / shares	3 Months Ended	12 Months Ended
	Jun. 30, 2020	Mar. 31, 2020
WARRANTS
Number of Warrants, Outstanding and exercisable, Beginning balance	125,034	288,517
Weighted-Average Exercise Price, Outstanding and exercisable, Beginning balance	$ 20.07	$ 40.27
Number of Warrants, Expired	(2,667)	(163,483)
Weighted-Average Exercise Price, Expired	$ (37.50)	$ (38.91)
Number of Warrants, Outstanding and exercisable, Ending balance	122,367	125,034
Weighted-Average Exercise Price, Outstanding and exercisable, Ending balance	$ 19.69	$ 20.07

XML 58 R47.htm IDEA: XBRL DOCUMENT

WARRANTS - Summary of common share purchase warrants outstanding (Details)	3 Months Ended
	Jun. 30, 2020 $ / shares shares
Class of Warrant or Right [Line Items]
Class of Warrant or Right, Number of Warrants	122,367
Warrant One [Member]
Class of Warrant or Right [Line Items]
Warrant exercise price \| $ / shares	$ 90.00
Class of Warrant or Right, Number of Warrants	15,658
Class Of Warrant Or Right Expiry Date	Mar. 31, 2023
Warrant Two [Member]
Class of Warrant or Right [Line Items]
Warrant exercise price \| $ / shares	$ 9.375
Class of Warrant or Right, Number of Warrants	64,025
Class Of Warrant Or Right Expiry Date	Aug. 14, 2022
Warrant Three [Member]
Class of Warrant or Right [Line Items]
Warrant exercise price \| $ / shares	$ 9.375
Class of Warrant or Right, Number of Warrants	42,684
Class Of Warrant Or Right Expiry Date	Mar. 31, 2022

XML 59 R48.htm IDEA: XBRL DOCUMENT

WARRANTS - Additional Information (Details) - shares	3 Months Ended	12 Months Ended
WARRANTS - Additional Information (Details) - shares	Jun. 30, 2020	Mar. 31, 2020
WARRANTS
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations	2,667	163,483
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	2 years 26 days

XML 60 R49.htm IDEA: XBRL DOCUMENT

COMMITMENTS AND CONTINGENCIES - Additional Information (Details) - USD ($)		3 Months Ended
	Feb. 25, 2015	Jun. 30, 2020	May 17, 2017
Stock Issued During Period, Shares, New Issues	1,753
Stock Issued During Period, Value, New Issues	$ 210,323
Loan received and repaid	$ 241,185
Percentage of Royalty on Sales		1.00%
China JV
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners			25.00%
JV Partner \| China JV
Equity Method Investment, Ownership Percentage			75.00%
Former Chief Technology Officer And New Chief Technology Officer [Member]
Stock Transferred To Lenders	2,098
Stock to be Reimbursed to Officers	2,134

XML 61 R50.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS - Additional Information (Details)	Jul. 01, 2020 USD ($)
Subsequent Event
Subsequent Event [Line Items]
Convertible loans received	$ 200,000

EXCEL 62 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 63 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 64 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 65 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 195 281 1 false 71 0 false 4 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://www.bionik.com/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 00100 - Statement - Condensed Consolidated Interim Balance Sheets Sheet http://www.bionik.com/role/StatementCondensedConsolidatedInterimBalanceSheets Condensed Consolidated Interim Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Condensed Consolidated Interim Balance Sheets (Parenthetical) Sheet http://www.bionik.com/role/StatementCondensedConsolidatedInterimBalanceSheetsParenthetical Condensed Consolidated Interim Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Condensed Consolidated Interim Statements of Operations and Comprehensive Loss Sheet http://www.bionik.com/role/StatementCondensedConsolidatedInterimStatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Interim Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 00300 - Statement - Condensed Consolidated Interim Statements of Changes in Shareholders' Equity Sheet http://www.bionik.com/role/StatementCondensedConsolidatedInterimStatementsOfChangesInShareholdersEquity Condensed Consolidated Interim Statements of Changes in Shareholders' Equity Statements 5 false false R6.htm 00400 - Statement - Condensed Consolidated Interim Statements of Cash Flows Sheet http://www.bionik.com/role/StatementCondensedConsolidatedInterimStatementsOfCashFlows Condensed Consolidated Interim Statements of Cash Flows Statements 6 false false R7.htm 10101 - Disclosure - NATURE OF OPERATIONS AND GOING CONCERN Sheet http://www.bionik.com/role/DisclosureNatureOfOperationsAndGoingConcern NATURE OF OPERATIONS AND GOING CONCERN Notes 7 false false R8.htm 10201 - Disclosure - BASIS OF PRESENTATION Sheet http://www.bionik.com/role/DisclosureBasisOfPresentation BASIS OF PRESENTATION Notes 8 false false R9.htm 10301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.bionik.com/role/DisclosureSignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 10401 - Disclosure - TECHNOLOGY AND OTHER ASSETS Sheet http://www.bionik.com/role/DisclosureTechnologyAndOtherAssets TECHNOLOGY AND OTHER ASSETS Notes 10 false false R11.htm 10501 - Disclosure - PREPAID EXPENSES AND OTHER RECEIVABLES Sheet http://www.bionik.com/role/DisclosurePrepaidExpensesAndOtherReceivables PREPAID EXPENSES AND OTHER RECEIVABLES Notes 11 false false R12.htm 10601 - Disclosure - INVENTORIES Sheet http://www.bionik.com/role/DisclosureInventories INVENTORIES Notes 12 false false R13.htm 10701 - Disclosure - EQUIPMENT Sheet http://www.bionik.com/role/DisclosureEquipment EQUIPMENT Notes 13 false false R14.htm 10801 - Disclosure - NOTES PAYABLE Notes http://www.bionik.com/role/DisclosureNotesPayable NOTES PAYABLE Notes 14 false false R15.htm 10901 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES Sheet http://www.bionik.com/role/DisclosureRelatedPartyTransactionsAndBalances RELATED PARTY TRANSACTIONS AND BALANCES Notes 15 false false R16.htm 11001 - Disclosure - SHARE CAPITAL Sheet http://www.bionik.com/role/DisclosureShareCapital SHARE CAPITAL Notes 16 false false R17.htm 11101 - Disclosure - STOCK OPTIONS Sheet http://www.bionik.com/role/DisclosureStockOptions STOCK OPTIONS Notes 17 false false R18.htm 11201 - Disclosure - WARRANTS Sheet http://www.bionik.com/role/DisclosureWarrants WARRANTS Notes 18 false false R19.htm 11301 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.bionik.com/role/DisclosureCommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 19 false false R20.htm 11401 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.bionik.com/role/DisclosureSubsequentEvents SUBSEQUENT EVENTS Notes 20 false false R21.htm 20302 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.bionik.com/role/DisclosureSignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 21 false false R22.htm 30403 - Disclosure - TECHNOLOGY AND OTHER ASSETS (Tables) Sheet http://www.bionik.com/role/DisclosureTechnologyAndOtherAssetsTables TECHNOLOGY AND OTHER ASSETS (Tables) Tables http://www.bionik.com/role/DisclosureTechnologyAndOtherAssets 22 false false R23.htm 30503 - Disclosure - PREPAID EXPENSES AND OTHER RECEIVABLES (Tables) Sheet http://www.bionik.com/role/DisclosurePrepaidExpensesAndOtherReceivablesTables PREPAID EXPENSES AND OTHER RECEIVABLES (Tables) Tables http://www.bionik.com/role/DisclosurePrepaidExpensesAndOtherReceivables 23 false false R24.htm 30603 - Disclosure - INVENTORIES (Tables) Sheet http://www.bionik.com/role/DisclosureInventoriesTables INVENTORIES (Tables) Tables http://www.bionik.com/role/DisclosureInventories 24 false false R25.htm 30703 - Disclosure - EQUIPMENT (Tables) Sheet http://www.bionik.com/role/DisclosureEquipmentTables EQUIPMENT (Tables) Tables http://www.bionik.com/role/DisclosureEquipment 25 false false R26.htm 31003 - Disclosure - SHARE CAPITAL (Tables) Sheet http://www.bionik.com/role/DisclosureShareCapitalTables SHARE CAPITAL (Tables) Tables http://www.bionik.com/role/DisclosureShareCapital 26 false false R27.htm 31103 - Disclosure - STOCK OPTIONS (Tables) Sheet http://www.bionik.com/role/DisclosureStockOptionsTables STOCK OPTIONS (Tables) Tables http://www.bionik.com/role/DisclosureStockOptions 27 false false R28.htm 31203 - Disclosure - WARRANTS (Tables) Sheet http://www.bionik.com/role/DisclosureWarrantsTables WARRANTS (Tables) Tables http://www.bionik.com/role/DisclosureWarrants 28 false false R29.htm 40101 - Disclosure - NATURE OF OPERATIONS AND GOING CONCERN (Details) Sheet http://www.bionik.com/role/DisclosureNatureOfOperationsAndGoingConcernDetails NATURE OF OPERATIONS AND GOING CONCERN (Details) Details http://www.bionik.com/role/DisclosureNatureOfOperationsAndGoingConcern 29 false false R30.htm 40201 - Disclosure - BASIS OF PRESENTATION (Details) Sheet http://www.bionik.com/role/DisclosureBasisOfPresentationDetails BASIS OF PRESENTATION (Details) Details http://www.bionik.com/role/DisclosureBasisOfPresentation 30 false false R31.htm 40301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.bionik.com/role/DisclosureSignificantAccountingPoliciesDetails SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.bionik.com/role/DisclosureSignificantAccountingPoliciesPolicies 31 false false R32.htm 40401 - Disclosure - TECHNOLOGY AND OTHER ASSETS - Intangible assets acquired (Details) Sheet http://www.bionik.com/role/DisclosureTechnologyAndOtherAssetsIntangibleAssetsAcquiredDetails TECHNOLOGY AND OTHER ASSETS - Intangible assets acquired (Details) Details 32 false false R33.htm 40402 - Disclosure - TECHNOLOGY AND OTHER ASSETS - Additional Information (Details) Sheet http://www.bionik.com/role/DisclosureTechnologyAndOtherAssetsAdditionalInformationDetails TECHNOLOGY AND OTHER ASSETS - Additional Information (Details) Details 33 false false R34.htm 40501 - Disclosure - PREPAID EXPENSES AND OTHER RECEIVABLES (Details) Sheet http://www.bionik.com/role/DisclosurePrepaidExpensesAndOtherReceivablesDetails PREPAID EXPENSES AND OTHER RECEIVABLES (Details) Details http://www.bionik.com/role/DisclosurePrepaidExpensesAndOtherReceivablesTables 34 false false R35.htm 40601 - Disclosure - INVENTORIES- Schedule of Inventories (Details) Sheet http://www.bionik.com/role/DisclosureInventoriesScheduleOfInventoriesDetails INVENTORIES- Schedule of Inventories (Details) Details 35 false false R36.htm 40602 - Disclosure - INVENTORIES - Additional Information (Details) Sheet http://www.bionik.com/role/DisclosureInventoriesAdditionalInformationDetails INVENTORIES - Additional Information (Details) Details 36 false false R37.htm 40701 - Disclosure - EQUIPMENT - Schedule of net equipment (Details) Sheet http://www.bionik.com/role/DisclosureEquipmentScheduleOfNetEquipmentDetails EQUIPMENT - Schedule of net equipment (Details) Details 37 false false R38.htm 40702 - Disclosure - EQUIPMENT - Additional Information (Details) Sheet http://www.bionik.com/role/DisclosureEquipmentAdditionalInformationDetails EQUIPMENT - Additional Information (Details) Details 38 false false R39.htm 40801 - Disclosure - NOTES PAYABLE (Details) Notes http://www.bionik.com/role/DisclosureNotesPayableDetails NOTES PAYABLE (Details) Details http://www.bionik.com/role/DisclosureNotesPayable 39 false false R40.htm 40802 - Disclosure - NOTES PAYABLE - Short term loan (Details) Notes http://www.bionik.com/role/DisclosureNotesPayableShortTermLoanDetails NOTES PAYABLE - Short term loan (Details) Details 40 false false R41.htm 40901 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details) Sheet http://www.bionik.com/role/DisclosureRelatedPartyTransactionsAndBalancesDetails RELATED PARTY TRANSACTIONS AND BALANCES (Details) Details http://www.bionik.com/role/DisclosureRelatedPartyTransactionsAndBalances 41 false false R42.htm 41001 - Disclosure - SHARE CAPITAL - Common shares issued (Details) Sheet http://www.bionik.com/role/DisclosureShareCapitalCommonSharesIssuedDetails SHARE CAPITAL - Common shares issued (Details) Details 42 false false R43.htm 41002 - Disclosure - SHARE CAPITAL - Additional Information (Details) Sheet http://www.bionik.com/role/DisclosureShareCapitalAdditionalInformationDetails SHARE CAPITAL - Additional Information (Details) Details 43 false false R44.htm 41101 - Disclosure - STOCK OPTIONS - Summary of stock options outstanding and exercisable (Details) Sheet http://www.bionik.com/role/DisclosureStockOptionsSummaryOfStockOptionsOutstandingAndExercisableDetails STOCK OPTIONS - Summary of stock options outstanding and exercisable (Details) Details 44 false false R45.htm 41102 - Disclosure - STOCK OPTIONS - Additional Information (Details) Sheet http://www.bionik.com/role/DisclosureStockOptionsAdditionalInformationDetails STOCK OPTIONS - Additional Information (Details) Details 45 false false R46.htm 41201 - Disclosure - WARRANTS - Summary of continuity schedule (Details) Sheet http://www.bionik.com/role/DisclosureWarrantsSummaryOfContinuityScheduleDetails WARRANTS - Summary of continuity schedule (Details) Details 46 false false R47.htm 41202 - Disclosure - WARRANTS - Summary of common share purchase warrants outstanding (Details) Sheet http://www.bionik.com/role/DisclosureWarrantsSummaryOfCommonSharePurchaseWarrantsOutstandingDetails WARRANTS - Summary of common share purchase warrants outstanding (Details) Details 47 false false R48.htm 41203 - Disclosure - WARRANTS - Additional Information (Details) Sheet http://www.bionik.com/role/DisclosureWarrantsAdditionalInformationDetails WARRANTS - Additional Information (Details) Details 48 false false R49.htm 41301 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Details) Sheet http://www.bionik.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails COMMITMENTS AND CONTINGENCIES - Additional Information (Details) Details 49 false false R50.htm 41401 - Disclosure - SUBSEQUENT EVENTS - Additional Information (Details) Sheet http://www.bionik.com/role/DisclosureSubsequentEventsAdditionalInformationDetails SUBSEQUENT EVENTS - Additional Information (Details) Details 50 false false All Reports Book All Reports bnkl-20200630.xml bnkl-20200630.xsd bnkl-20200630_cal.xml bnkl-20200630_def.xml bnkl-20200630_lab.xml bnkl-20200630_pre.xml http://fasb.org/us-gaap/2019-01-31 http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true ZIP 68 0001104659-20-093964-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-20-093964-xbrl.zip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�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

Finished Goods